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Abstract 
Electroanalytical Sensors using Lipophilic Cyclodextrins 
Lipophilic dialkylated-a-, (3- and y-cyclodextrin derivatives were used as selective 
ionophores for a series of clinically relevant ammonium ions, and as enantioselective 
ionophores for both a- and p-aryl ammonium ions. 
Sensitive and selective potentiometric detection of the local anaesthetics lidocaine and 
bupivacaine was achieved by using 2,3,6 trioctyl-P-cyclodextrin as the ionophore, 
leading to micromolar detection limits. Interference studies showed that the simulated 
clinical electrolyte background caused minimal interference whereas organic 
interferents of similar size and charge caused some perturbation of the electrode 
response at a concentration of 10 mmol dm" . An electrode comprising a plasticised 
biocompatible membrane matrix, TECOFLEX, with 2,6 didodecyl-p-cyclodextrin was 
incorporated in a flow injection analysis system and the response to lidocaine studied in 
the presence of human serum. Human serum caused no adverse effects to the 
electrochemical response of the electrode. These electrodes are, therefore, very suitable 
for on-line detection of local anaesthetics. 
Potentiometric detection of tricyclic antidepressants using didodecyl-a-, p- and y-
cyclodextrins as the ionophore, gave micromolar detection limits. Interference from 
simulated clinical electrolyte background and selected organic interferents gave similar 
results to those discussed above. In order to lower the detection limit to sub-nanomolar 
levels modified amperometric electrodes were assembled by depositing a membrane 
comprising plasticised TECOFLEX, 2,3,6 triethyl-P-cyclodextrin and TKB on the 
working electrode of a screen printed electrode. 
Lipophilic 2,6 didodecyl-a- and P-cyclodextrins exhibited enantiomeric discrimination 
in the binding of propranolol, ephedrine, amphetamine and methamphetamine. These 
results were confirmed using potentiometric and NMR techniques. 
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Chapter One 
Introduction 
1.1 Clinical Analysis and Enantiomer Discrimination 
This thesis is based upon the application of alkylated cyclodextrins; in clinical analysis 
and enaniiomer discrimination. This chapter discusses the processes involved in 
molecular recognition (section 1.2), the electrochemical sensors designed for analysis 
of clinically relevant substances (section 1.3). Sections 1.4 - 1.8 discuss the propert ies 
and uses of cyclodextrins. 
1.2 Molecular Recognition 
1.2.1 Host Structure 
Molecular recognition is the basis of many biochemical processes, but it has only been 
relatively recently that synthetic molecules have been produced that can recognise other 
ions and molecules. The host molecules most often used in these areas of research are 
either modified naturally occurring receptors or synthetic molecules which are often 
macrocycles. To be suitable for ion recognition the molecule should typically possess 
the following features11,2), 
1. A stable conformation that defines a 'cavity' into which polar groups may be 
directed (binding sites), while non-polar groups form a lipophilic shell around the 
'cavity'. 
2. There should be preferably 4 to 8, but no more than 9 co-ordination sites. 
3. High selectivity may be achieved with convergent co-ordination. 
4. The ligand should be sufficiently flexible to allow fast ion-exchange. 
These criteria have been statisfied by a variety of hosts such as spherands, 
cryptaspherands, cryptands, crown ethers and certain naturally occurring antibiotics 
such as valinomycin, all of which have been studied as hosts. 
The degree of pre-organisation in the host has a profound influence upon both the 
binding strength and the selectivity of the host. Cram [ 3 1 studied a series of macrocyclic 
hosts and showed that spherands are highly preorganised, possessing a single 
2 
conformation ideally suited to the binding of lithium. The free energy cost for binding 
site organisation had already been paid during synthesis and therefore did not contribute 
to a less favourable AG 0 c o m pi e x for complex formation. Thus the spherand (figure 
1.2.1.1) was preorganised for binding. As less preorganised compounds are considered 
(crown ethers), the less favourable AG0COmpiex can be attributed to a greater need for 
binding site reorganisation prior to complexation. 
Although binding site preorganisation to some extent determines the binding power of 
the host, complementarity of the host and guest binding sites is central in determining 
the extent of structural recognition. The binding energy at a single contact site is at 
most a few kilojoules per mole (hydrogen bonding of alcohols, bond strength = 20 
kJ/mol), much lower than that of a covalent bond (C-H bond (av.) = 420 kJ/mol). 
Contacts at several sites between the host and guest are required for formation of 
complexes. Such contacts depend on the relative placements of binding sites in the 
complexing partners. This aspect is fundamental in chiral recognition. The host is 
chiral, and binding site complementarity has a chiral as well as structural aspect. For 
chiral discrimination to occur, the binding interaction of the host must favour one guest 
CH 3 
o H3C CH 3 o o ' 6 CH 3 H 3C 
O O 
O o Ff3C s CH 3 
H 3 C CH 3 o 
CH 3 
Figure 1.2.1.1 The preorganised Spherand-6. 
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enantiomer. The other enantiomer must give rise to an unfavourable interaction, such as 
a repulsive steric interaction. 
The ability to selectively recognise a specific guest species has led to host molecules 
being used in a variety o f chemical sensors. However, host-guest complexation is not 
sufficient on its own, the complexation must lead to a change in a detectable physical 
property. The properties most frequently used are electrochemical^ and optical [ 5 ' 6 ] . 
1.2.2 Recognition of ammonium ions and related structures 
Ammonium ions frequently play an important role in clinical chemistry so it is not 
surprising that receptor molecules capable o f recognising such substrates have been 
developed. 
Crown ether macrocycles are the host molecules which have been studied most often in 
this area. Primary ammonium ions are bound via the anchoring o f the protonated 
ammonium group through three C3-related +NH—O hydrogen bonds, as shown in figure 
1.2.2.1. 
H 
R 
r Ar O 
CONRF O O 
H 
N 
*'// O O CONRF H 
O 
Figure 1.2.2.1 Binding o f a primary ammonium ion by an 18-crown-6 derivative. 
Chiral polyethers have been used to bind chiral ammonium ions wi th fairly high 
enantiomer selectivity. The most successful o f these have been devised by Cram | 7 ] and 
Lehn [ 8 ] . Figure 1.2.2.2 shows the structure o f these host molecules. The host devised 
by Cram was tested using partition experiments (between D2O and a solution containing 
4 
CD3CN and CDCI3) and showed enantioselective binding towards a series o f chiral a-
amino acids. The tetracarboxamide 18-crown-6 derivative, developed by Lehn 1 8 1 , bound 
the (+)-a-phenylethylammonium ion in preference to its enantiomer (K+/_ = 2.6), 
Selectivity against selected other ammonium ions was also investigated, for example, 
the selectivity over the ephedrinium ion (a protonated secondary amine) when present as 
the interferent was - log Kp^ EPH = 2 . 0 . However, the selectivities against inorganic 
cations such as sodium ( - l o g A T ^ ^ =1 .4) or potassium (-logKj^^ = 0 . 5 ) were 
poor. 
O 
1 
O O 
o o \ 
o 
7 Cram 
N N O J o o 
o o 
o o 
T o o 
N o N 
8 Lehn 
Figure 1.2.2.2 Chiral crown ether derivatives. 
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1.3 Clinical Analysis Electrodes 
The area o f clinical analysis is concerned with the production o f simple diagnostic 
probes which can be used by an unskilled user, either continuously in an on-line process 
or discretely as a 'throw away' device. This branch o f research is rapidly expanding as 
the demand increases for more sensitive and selective detection o f an ever growing 
number o f clinical analytes' 9 , 1 0 1. Typical areas o f interest in clinical analysis are defined 
in table 1.3.1. Many different electroanalytical techniques have been used to aid the 
1 1 1 1 9 1 ^ 1 
analysis o f a given ion 1 ' . O f growing importance has been the use o f 
potentiometric and voltammetric electrochemical sensors. These techniques have both 
been successfully utilised in the areas o f clinical analysis and pharmaceutical quality 
control, with perhaps the two most widely known systems being the determination o f 
blood glucose (voltammetric) and blood calcium levels (potentiometric). 
Analytical Application 
Research and Development 
(pharmacokinetics, metabolism) 
Analysis o f raw products 
(pharmacopoeia monography) 
Analysis o f drug formation 
Analysis in biological fluids: drug therapy monitoring 
drug intoxication 
drug addiction 
doping 
Table 1.3.1. Applications to which drug analysis is applied. 
1.3.1 Potentiometric Electrochemical Methods 
The first application of potentiometric sensors in clinical analysis was the development 
o f the pH electrode for the determination o f blood pH. Since then the number o f 
analytes to which these sensors have been applied has grown rapidly' 1 4 1 . The 
fundamental process occuring in the most common type o f potentiometric sensor (the 
polymer membrane-based ion-selective electrode) is a guest-induced selective change in 
the charge separation across the interface between the polymer membrane and the 
aqueous sample solution. Hence by the synthesis o f highly lipophilic and selective 
complexing agents, the specificity o f these electrodes can be optimised for a given 
analytical task [ 1 5 1. This has led to efforts over the last few years being directed to the 
synthesis o f new and more selective ionophores, such as the highly sensitive and 
selective lithium ionophore synthesised by Parker 1 ' 6 ' (figure 1.3.1.1). A n electrode 
based on this ionophore showed a Nernstian gradient (61 mV/decade) with a detection 
l imit o f 6.3 x 10"6 mol dm"3. The selectivity in a simulated background of clinical 
cations (1.50 x 10"1 mol dm"3 NaCl, 4.3 x 10"3 mol dm"3 KC1, 1.26 x 10"3 mol dm"3 
CaCl 2 , 0.9 x 10"3 mol dm"3 M g C l 2 ) was also reported, - log Kp£clin = 3.25. 
/ \ O O 
\ N 
\ 
N \ / \ \ / o o 
o o 
Figure 1.3.1.1 Derivatised 14-crown-4 Lithium Ionophore. 
Advances in ionophore technology have been made together with improvements in 
other areas. The miniaturisation o f these sensors has led to the use o f more reliable ion-
selective f ie ld effect transistors ( ISFETs) [ 1 7 1 8 ] . ISFETs have been developed for Ca 2 + , 
K + , Na + , N H / and pH, and have been used for in vivo monitoring o f Ca 2 + and K + . This 
has led to the production o f devices at a lower cost, wi th greater reproducibility and the 
potential for multiple sensors on a single chip [ 1 9 ] . 
A major problem with potentiometric sensors in clinical analysis is the appearance o f a 
shift in the standard potential o f the electrode (E°) when changing f rom an aqueous 
electrolyte to a protein containing solution. This shift is due to the induction o f a 
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membrane asymmetry potential in inherently symmetric membranes through a 
contamination o f the membrane surface by proteins' 2 0 1. To overcome this problem in 
clinical analysis, several approaches have been investigated. 
1. The alteration o f the calibration solutions to ones more closely matching the blood 
matrix. Work performed by Covington and Kataky' 2 ' 1 took the first steps by 
matching the calibration matrix in terms o f ionic composition, ionic strength and 
pH. This led to the reduction in the liquid-junction and activity coefficient bias. 
However, the calibration solutions did not originally contain protein, although this 
has since been rectified' 2 2 1 . 
2. An approach which has been applied for some time in other medical applications 
involved the surface treatment o f a bulk polymer with an outer coating. This may 
be necessary as conventional materials do not often meet the demands required o f 
them in terms o f both their surface and bulk properties' 2 3 1. Cosofret and co-
workers' 2 4 1 have applied this approach to ion-selective electrodes by applying a layer 
o f poly-2-hydroxy ethylmethacralate (poly-HEMA) to the blood contacting face o f 
the membrane. Unfortunately the equilibration time o f the sensor was quite long 
(24 hours). However, the electrode response was excellent in whole blood samples, 
showing very little reduction in the slope o f the calibration curve, or any increase in 
the membrane resistance for a period o f up to fourteen days. After this time, the 
layer o f poly-HEMA began to peel away f rom the bulk PVC. 
3. The polymer matrix used in the ion-selective electrode can be substituted for a more 
biocompatible material' 2 5 1. This simple approach was applied by Cosofret ' 2 6 1 and 
D'Orazio ' 2 7 1 . Both groups replaced the PVC in the polymer membrane by the 
aliphatic polyurethane TECOFLEX. The polyurethane had been observed 
previously to show excellent biocompatibility' 2 8 1 . Indeed both groups successfully 
showed that this approach led to improvement in the stability o f ISEs in the 
presence o f biological media. 
4. Recently a novel approach to the problem was proposed by Meyerhoff" 2 9 1 . I t was 
demonstrated how the emission o f low levels o f nitric oxide, a potent platelet 
antiaggregation reagent, resulted in a marked decrease in protein coating for the 
8 
electrode. The sensing membrane was composed o f three layers, the first and third 
are cast as normal, the second contained N-N'-dimethylhexanediamine nitric oxide 
adduct (DMHD/N2O2). This adduct is known to generate NO spontaneously in an 
aqueous environment. In the polymer membrane the release rate o f NO from the 
adduct was reduced, allowing the membrane to be used for several days. 
Importantly the response characteristics o f the electrode were not compromised by 
the addition o f the adduct. 
Wi th these developments in reducing the problem of protein interference and the 
synthesis o f better ionophores, the f u l l potential o f this type o f sensory system for the 
detection o f analytes in whole blood is beginning to be realised. 
Whilst ISEs can be used in whole blood, an area to which they are often applied is in the 
quality control o f pharmaceutical preparations. Quality control is relatively straight 
forward for ISE systems since the concentration o f the drug analyte is often quite high 
(e.g. the standard lidocaine injection solution is 1 % w/v lidocaine hydrochloride in an 
aqueous background) and the preparations are often aqueous with no protein or other 
interferents being present. 
1.3.2 Voltammetric Electrochemical Methods 
The main advantage o f potentiometric detection is its high selectivity. This, however, is 
coupled wi th a detection range that is limited to approximately 10"6 mol dm" 3, and many 
drugs are present in the body at much lower levels. The sensitivity o f voltammetric 
detection had been hindered by the generally low selectivity for a given analyte 
observed in biological media. The deliberate modification o f the electrode surfaces has 
led to improvements not only in the selective detection o f the analyte but also in an 
increased detection range, through preconcentrauW 1 2 1. 
The first application o f voltammetric analysis to clinical analysis was the Clark oxygen 
electrode which was first used to measure dissolved oxygen in blood in 1956. The 
sensor involves a relatively simple design consisting o f a platinum working electrode 
and a Ag|AgCl reference/counter electrode covered with a Teflon membrane through 
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which the dissolved oxygen may pass into the electrolyte solution behind the 
membrane. It was not long before the sensor was modified, and in 1962 the electrode 
was coated with a further membrane layer which held in place an enzyme, glucose 
oxidase. The membrane between the electrode and the enzyme allowed the passage of 
hydrogen peroxide but prevented the passage o f potential interferents e.g. ascorbic acid 
to the electrode surface. The membrane between the glucose oxidase and sample 
solution allowed the diffusion o f the substrate and oxygen to the enzyme. This was 
originally accomplished by sandwiching the enzyme between a cellulose acetate and a 
polycarbonate membrane. This constituted the first glucose electrode. 
Since this first voltammetric sensor, much research has been done in both simple 
chemically modified voltammetric sensors and in enzyme linked systems. Work by 
Murray [ 3 0 ] showed that modification o f glassy carbon and graphite surfaces with 
ethylenediamines via organosilane chemistry was possible as a first step towards 
assembling electrochemically active centres on the modified surface o f the electrode. 
Molecules commonly used as ionophores have been applied as surface modifiers to 
working electrodes in voltammetric analysis. Polymerised calixarenes (figure 1.3.2.1) 
were applied by Svehla et alPl] to enhance the accumulation o f lead(II), copper(II) and 
mercury(II) ions on a carbon paste electrode prior to anodic stripping. Their results 
demonstrated the ability o f the polymerised surface to preconcentrate these trace metal 
ions and hence allow their analysis. Unfortunately, the presence o f alkali metal ions in 
the sample solutions was found to have an adverse effect on the electrode response, due 
to the preferential binding o f these ions by the calixarenes. 
The idea o f preconcentration is not new. Chaney and Baldwin showed that adriamycin, 
a chemotherapeutic drug, could be preconcentrated onto an unmodified carbon paste 
electrode [ 3 2 ] allowing a detection l imit o f 10"8 mol dm"3 for the drug in urine. The use o f 
a modified electrode surface has the advantage o f making the preconcentration more 
selective, by prohibiting the adsorption o f certain species onto the electrode surface. 
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Figure 1.3.2.1 A polymerised calixarene. 
Nafion coated carbon paste electrodes have recently been used in the determination o f 
three important p-agonist drugs by Smyth [ 3 3 ] . Nafion, a fluorinated polymer, was 
chosen as it possesses a large number o f anionic sites which reduce the interference 
f rom anionic constituents o f the sample solution, and help attract the cationic analyte. 
Work with unmodified electrodes had shown a loss o f electrode activity and this was 
believed to be due to the adsorption o f interfering electroactive species f rom the sample 
solution. Therefore the Nafion f i l m had two purposes, firstly to prevent the adsorption 
o f interferents onto the carbon paste and secondly as a means o f preconcentrating the 
analytes as required to reach the detection levels needed for biological samples. Using 
8 3 
such a Nafion modified electrode, a detection l imi t o f 2.5 x 10" mol dm" salbutamol 
was achieved. 
The utility o f a sensor is determined by its selectivity. Hence sensors which combine 
the high selectivity o f a biological element with a physical transducer, can be regarded 
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as ideal analytical tools for a variety o f analytes. Table 1.3.2.1 lists the different 
biological elements that may be combined with various transducers'341. 
Biological Element Transducer Measurement 
Enzymes Solid electrodes Voltammetry 
Microorganisms ISEs 
Whole Cells (animal, GSE Potentiometry 
vegetable) FET 
Antibodies photodiode, photomultiplier 
(+fibre optic) 
Optical 
Antigens Thermister Calorimetry 
Piezoelectric crystal Mass Change 
Table 1.3.2.1. Sensor components and detection modes. ISE: ion-selective electrode, 
GSE: Gas-sensing electrode, FET: Field effect transistor. 
The combination o f an enzyme layer wi th an electrochemical sensor provides the 
advantages o f specificity o f the enzyme system with the sensitivity o f voltammetric 
analysis. The major problem arising from the use o f enzymes has been their 
encapsulation, how to manage it without losing enzymatic activity and without leaching 
o f the enzyme. 
The simplest approach is based on membrane entrapment, where the enzyme is held 
behind a membrane (dialysis membranes are normally used). This approach allows the 
enzyme to maintain its activity but it can easily leach away. Gel entrapment (using for 
instance gelatin, starch or polyacrylamide)and cross-linking with a Afunctional agent 
such as glutaraldehyde have also been used. These methods work fairly well on the 
whole, although in some cases enzymatic activity can be lost due the cross-linking 
reaction. Recently enzymes have been immobilised directly onto the electrode surface 
via adsorption, covalent attachment or entrapment within a polymer membrane cast onto 
the electrode surface' 3 5 ' 3 6 1. The ability to immobilise an enzyme directly at the electrode 
surface without affecting its activity has led to the production o f sensors with faster 
response times (fewer rate limiting steps through diffusion). Accompanying the 
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improved immobilisation techniques, the removal o f an oxygen dependence f rom the 
commonest enzyme group used, the oxidases, has been achieved by two methods: 
i . By the addition o f a redox mediator that shuttles electrons between the electrode 
and the enzyme allowing the rapid reoxidation o f the enzyme 
i i . Directly wiring the enzyme to the electrode through an electroactive conducting 
polymer. 
The major breakthrough for the mediator approach was the use o f ferrocene derivatives. 
Cass [ 3 7 ] was the first to use the system successfully wi th l,l '-dimethylferrocene as the 
mediator in a glucose sensor. Indeed new glucose sensors using ferrocene and its 
derivatives are still being reported' 3 8 '. 
Ferrocene derivatives are not the only mediators available. Turner 1 3 9 1 has used 
tetrathiafulvalene to facilitate electron transfer f rom the glucose oxidase to a pyrolytic 
graphite electrode with excellent results. The sensor showed a linear response to 
glucose over the clinically relevant range (0 - 2.5 x 1 0 2 mol dm" 3), however, the 
response time was slow (60 s). Another mediator used was benzoquinone. The 
mediator was held in an a-cyclodextrin polymer film within which the glucose oxidase 
was attached to the polymer via glutaraldehyde. The mediator is believed to be 
included within the cyclodextrin cavi ty [ 4 0 l This novel approach produced a glucose 
sensor which showed a linear response to glucose over the clinically relevant range, and 
showed little interference f rom substances such as ascorbic and uric acid. 
Much interest has been directed at "wi r ing" enzymes directly to electrodes since this 
means the response time of the system may be decreased, and the current drop due to 
leaching o f the mediator or enzyme would be irrelevant. One very interesting sensor 
employing this technique was described by Heller [ 4 1 ] . The sensor consisted o f four 
layers, 
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1. The glucose sensing layer. 
2. The barrier layer to prevent electrical contact between the sensing layer beneath 
and the interference-eliminating layer above. 
3. The interferent eliminating layer 
4. The outer biocompatible layer. 
The glucose sensing layer consists o f the redox polymer 
[(vinylimidazole)Os(bpy)2Cl] + / 2 + , complexed with a genetically engineered glucose 
oxidase and crosslinked with poly(ethylene glycol) diglycidyl to form an electron-
conducting hydrogel. The sensor was designed to measure glucose in the subcutaneous 
tissue through long term implantation (sensor dimensions 0.125 mm length, 0.25mm 
diameter). The sensor gave a stable, reproducible and accurate response within 60 s. 
Glucose sensors are the most common application o f enzyme based voltammetric 
electrodes due to the excellent properties o f glucose oxidase and the high clinical 
demand for glucose analysis. Other oxidase and oxidoreductase enzymes have been 
used in sensors. For example, L-lactate oxidase has been immobilised on a platinum 
electrode to allow the continuous monitoring o f lactate in the blood stream or tissue'4 2 1. 
In clinical analysis the current trend is towards in vivo or on-line analysis o f specific 
analytes. This has led to an increased research effort into the miniaturisation o f sensor 
arrays for both potentiometric and voltammetric sensor types. Several approaches have 
been used. Ion-selective field effect transistors (ISFETs) have always shown the 
potential to be used in this area, but have suffered f rom poor encapsulation technology. 
Recently however this has been improved and ' long term' stability o f these sensors has 
been achieved' 4 3 1. Another approach uses thin film technology, where a small flexible 
sensor can be produced on a polymer backing. This approach has shown itself to be 
viable for voltammetric enzyme electrodes' 4 4 ' 4 5 1. 
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1.4 Cyclodextrlms 
Cyclodextrins were first isolated by Vi l lers ' 4 6 1 in 1891 as a degradation product o f starch 
produced by the action o f the enzyme glucosyltransferase. They were later characterised 
as cyclic oligosaccarides in 1904 by Schardinger'4 7'. Work performed by French' 4 8 ' 4 9 1 
and others went on to determine the accurate molecular weight o f the common 
cyclodextrins and also to design a route for the synthesis o f pure cyclodextrins. 
1.4.1 Physical Properties 
Cyclodextrins are a-l ,4-l inked oligosaccarides'5 0 1, wi th a toroidal shape (see figure 
1.4.1.2). Each o f the chiral glucose units possesses a r igid 4 Q chair conformation 
(figure 1.4.1.1). The most common cyclodextrins are built up from 6, 7 and 8 glucose 
units and are known as a-, p-, and y-cyclodextrins. Table 1.4.1.1 summarises some o f 
the important physical properties o f these compounds. 
a 
C Y C L O D E X T R I N 
P Y 
Number o f glucose units 6 7 8 
Number o f chiral centres 30 35 40 
Molecular mass 972.86 1135.01 1297.15 
External diameter (pm) 1370-1460 1530-1540 1690-1750 
Internal diameter (pm) 470-520 600-650 750-850 
Volume o f cavity (ran 3) 0.176 0.346 0.510 
p K a o f hydroxyl groups 12.1 - 12.6 (all) 
Solubility in water (grams 14.50 1.85 23.20 
per 100 c m 3 , 2 5 ° C ) 
Molarity o f saturated 0.149 0.016 0.179 
solution [ M ] 
Melt ing and 551 572 540 
decomposition point (K) 
Table 1.4.1.1. Physical properties o f cyclodextrins. 
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The formation o f cyclodextrins o f fewer than six glucose units is not known. 
Conformational studies using potential energy calculations performed by Sunderarajan 
et a/. [ 5 1 ] showed this to be a consequence o f ring strain upon cyclisation. Higher 
homologues containing up to twelve glucose sub-units have been reported in the 
literature f 5 2 ]. These larger macrocyclic ring structures do not form the regular toroidal 
structure seen in the common 6, 7 and 8 membered cycles due to the absence o f the 
intramolecular hydrogen bonding secondary structure seen in the common 
cyclodextrins. 
As can be seen in figure 1.4.1.2 the preferred Ci conformation o f the glucose units leads 
to the secondary hydroxyl groups being situated on the wide face and all the primary 
hydroxyls on the other. The cavity interior is lined by the hydrogen atoms o f C(3) and 
C(5) and the glycosidic oxygen bridges. The consequence o f these structural features is 
the generation o f a hydrophobic, Lewis basic, cavity with hydrophilic rims. 
OH 
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HO 
o 
OH 
H 
OH 
o 
OH 
HO OH 
0 \ o o o 
H HO HO H I H 
OH HO 
H 0 n o 
HO 
OH 
O 
HO OH 
OH O O 
HO 
O 
OH 
Figure 1.4.1.1. Chemical structure and numbering scheme for P-cyclodextrin. 
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/ \ / 
/ \ / 
- Primary Hydroxyls 
Figure 1.4.1.2. Functional scheme of the cyclodextrin torus. 
1.4.2 Intramolecular Hydrogen-bonding 
A major feature o f cyclodextrin structure relates to their ability to form intramolecular 
hydrogen bonds. As depicted in figure 1.4.2.1, the C(2) hydroxyl group o f one glucose 
sub-unit can act as a hydrogen bond acceptor for the C(3) OH group o f an adjacent 
glucose uni t [ 5 3 ] . The formation o f this series o f hydrogen bonds around the secondary 
face rigidities the macrocycle' 5 1 '. 
O H 
O O H 
O 
O 
. O O On i it 11 H H O 
O H O 
Figure 1.4.2.1. 0 (2 ) HO(3) intramolecular hydrogen bonding in cyclodextrins. 
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1.4.3 Applications of Cyclodextrins 
A wide range o f possible guest molecules may be included by cyclodextrins. Due to 
this, and the fact that complex formation induces changes in the properties o f the 
included substance, cyclodextrins have been used in many different fields o f study. 
1. Cyclodextrins and their derivatives have been widely employed as the substrate-
recognition moieties in artificial enzymes. The cavity o f the cyclodextrin acts as a 
specific discriminating and orientating site. A l l the reactions catalysed by 
cyclodextrins proceed via the complexes between them and their substrates, in 
which a chemical reaction takes place. In most cases, the hydroxyl residues o f the 
cyclodextrin are responsible for the catalytic functions. Large increases in reaction 
rates have been achieved, since the catalysis occurs intramolecularly in the 
cyclodextrin-substrate complex' 5 4 ' 5 5 1 . 
2. The capability for changing the physicochemical behaviour o f the guest molecule 
through complexation has received considerable pharmaceutical interest' 3 6 ' 5 7 1. 
Indeed the advantages o f this are numerous and include, the alteration o f the drug 
release rate and solubilisation o f sparingly water soluble compounds leading to the 
increase in the drugs bioavailability. Furthermore, the chemical and photochemical 
stability o f the drugs in their preparation are improved' 5 8 1 due to the reduction in the 
rates o f hydrolysis and photo decomposition' 5 9 1. 
3. As is discussed in more detail in section 1.7.1, alkylated cyclodextrins are used in 
HPLC and GLC as both stationary and mobile phases to facilitate 
enantiodiscrimination' 6 0 1. 
4. In capillary zone electrophoresis (CZE) cyclodextrins are being added as a chiral 
agent to the background electrolyte to allow the separation o f enantiomers' 6 1 ' 6 2 1. 
5. Derivatised cyclodextrins have also been used in sensors, both fluorescent and 
electrochemical. The fluorescent sensor relies on the attachment o f a chromophore 
to the cyclodextrin ring. These chromophore-modified cyclodextrins show a change 
in fluorescence and absorption intensities upon complexation o f a guest molecule. 
Ueno et al has designed several systems, one o f which had a 
p-dimethylaminobenzyl moiety attached to an a-cyclodextrin, and was used for the 
detection o f aliphatic alcohols such as n-pentanol' 6 3 1. Another system used 
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N-dansyl-L-leucine as a pendent arm to modify both 0- and y-cyclodextrins. These 
modified cyclodextrins were used as fluorescent indicators for a series o f steroidal 
compounds 1 6 4 1. As potentiometric sensors the cyclodextrins were rendered 
lipophilic by alkylation of either two or three o f the hydroxyls groups on each 
monomer unit. This allowed the cyclodextrins to be used in both ion-selective 
electrodes1 6 5 1 and on modified screen printed electrodes1 6 6 1. 
6. Cyclodextrins have also been used as chiral solvating agents (CSA) allowing the 
determination o f enantiomeric purity by N M R [ 6 7 1 . 
1.5 Cyclodextrin Inclusion Complexes 
The most characteristic property o f cyclodextrins is their ability to form 1:1 or 2:1 
inclusion complexes wi th a variety o f guest molecules, including organic or inorganic 
compounds o f a neutral or ionic nature 1 6 0 1. Cyclodextrins are capable o f forming 
inclusion complexes with molecules o f a size that is compatible with the dimensions o f 
the cavity. It is this geometric factor, rather than chemical factors, which dictates 
whether a guest molecule w i l l be included in the cyclodextrin cavity 1 6 8 1 . Figure 1.5.1 
shows a representation of cyclodextrin inclusion complex formation with p-xylene. 
A 
X 
T 
Figure 1.5.1. Schematic illustration o f inclusion complexation o f p-xylene by a 
cyclodextrin. The small circles represent the water molecules included in the 
cyclodextrin cavity. 
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The inclusion complexes of cyclodextrins with aromatics and various other guest 
molecules have been widely studied using a variety of techniques such as UV/VIS l : > 7 ] , 
induced circular dichroism1691, NMR [ 7 0 ! and electrochemical1711 methods. 
1.5.1 Factors Contributing to the Free Energy of Binding 
The inclusion of a guest molecule into a cyclodextrin cavity involves the substitution of 
the included water molecules by the less polar guest. This process is an energetically 
favoured interaction of the relatively nonpolar guest molecule with an imperfectly 
solvated hydrophobic cavity, and both entropy and enthalpy changes play important 
roles [ 7 2 ]. The 'driving force' for complexation involves the contribution of various 
effects whose role depends upon the particular combination of guest and host 
cyclodextrin. These effects are; 
i . substitution of the energetically unfavourable polar-apolar interactions between the 
included water and the cyclodextrin cavity, and between water and the guest, by 
the more favoured apolar-apolar interaction between the guest and the cavity, and 
the polar-polar interaction between bulk water and the released cavity-water 
molecules 
i i . cyclodextrin-ring strain release on complexation 
i i i . van der Waals interactions 
iv. in the case of some guests, hydrogen-bonding between hosts and guest. 
Water substitution by a guest molecule of appropriate size, shape and polarity appears 
universal. Water molecules within the cyclodextrin cavity are incapable of satisfying 
their tetrahedral hydrogen-bonding capacity unlike those molecules in the bulk. 
Therefore, those included water molecules may be regarded as being of relatively high 
energy. The expulsion of these water molecules therefore favours complex formation 
by a gain in entropy1731 and a favourable change in enthalpy from good hydrogen-
bonding of the displaced water to bulk water. The cavity of cyclodextrins larger than y 
are so wide that their included water molecules show properties resembling bulk water, 
consequently the driving force of complexation decreases making these large 
cyclodextrins slightly weaker complexing agents. 
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Van der Waals, hydrophobic interactions and hydrogen-bonding all contribute to the 
favourable enthalpy change upon complexation. Van der Waals forces generally 
originate from dipole-dipole interactions and are weak. Their energy is proportional to 
molecular polarisability, which in turn is proportional to molecular refraction. There is 
a linear correlation between molecular refraction and the dissociation constant of 
cyclodextrin complexes, implying that van der Waals forces are a major contributor to 
complexation'731. 
The release of ring strain upon complexation is only significant in the case of a-
cyclodextrin. This is because the structure of ct-cyclodextrin hydrate is distorted due to 
the existence of two possible intramolecular hydrogen-bonds between adjacent glucose 
units being open, allowing the inward rotation of one of the glucose units. However, 
the intramolecular hydrogen-bonds between the C-2 hydroxyl group of one glucose unit 
and the C-3 hydroxyl (acting as the proton donor) of an adjacent glucose unit are all 
formed in both (3- and y-cyclodextrins giving them 7 and 8 intramolecular hydrogen 
bonds respectively. 
1.6 Alkylated Cyclodextrins 
The selective derivatisation of cyclodextrin molecules has become an active area of 
research160'74', spurred on by the need to alter the inclusion ability and solubility 
characteristics of the native cyclodextrin. One branch of this research led to alkylated 
cyclodextrins1751. 
1.6.1 Inclusion complexes of alkylated cyclodextrin 
The inherent chirality of cyclodextrin molecules allows them to form diastereomeric 
complexes following inclusion of a chiral guest. This led in turn to attempts to use 
cyclodextrins as reagents for chiral resolution since the diastereoisomers possess 
different free energy values which may aid the separation of the pair of enantiomers. 
This has been investigated in two different approaches: the use of cyclodextrins in chiral 
stationary phases and as highly soluble modified cyclodextrins as mobile phase 
additives. As stationary phases, the native cyclodextrins often showed poor 
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resolution1 , possibly due to the rigid symmetry of the cavity. This led to the 
investigation of functionalised cyclodextrins in which the hydroxyl groups were 
acylated or alkylated. The benefits of functionalisation included an increase in the 
lipophilicity of the cyclodextrins, making them suitable for use in chromatographic 
applications and in solvent polymer membranes. In addition functionalisation led to a 
distortion of the cavity by removal of some of the intramolecular hydrogen bonds. It 
was hoped that the distortion of the cavity would led to greater enantioselectivity and to 
some extent this has been born out by experimental results'761. The interruption of the 
intramolecular hydrogen bonding leads to a more flexible structure which then allows 
greater chiral discrimination. This reduction in the pre-organisation of the host allows 
closer host-guest interactions. Recent molecular modelling studies on the complexes of 
a-pinene with permethylated a- and P-cyclodextrins performed by Black et al.[11] 
showed that changes in the host cyclodextrin structure did occur, allowing a better 
accommodation or 'induced fit' of the guest molecule. 
1.6.2 Chiral recognition through induced fit 
Alkylated cyclodextrins have been used as the host molecule in a wide variety of 
applications which require the separation of enantiomers. Without the hydrogen 
bonding to rigidly define the structure, the molecules are more flexible.. Good examples 
of this are seen in the complex between per-O-methyl-a-cyclodextrin and mandelic 
acid' 7 8 1 and in the complex of 2-chloropropionate with 3-acetyl-2,6-dipentyl-(3-
cyclodextrin'791. It was noted that in the presence of (R)-mandelate, the cyclodextrin 
cavity was substantially less symmetrical (and somewhat elliptical in nature) compared 
to the complex with the (S)-enantiomer. Another difference, and probably the most 
important in determining the enantiomer selectivity, is the orientation of the mandelate 
aromatic ring within the cavity. With the (S)-enantiomer the ring is parallel to the z-
axis of the cavity, whereas in the case of the (R)-enantiomer the phenyl ring is inclined 
by approximately 20° to the z-axis within the cavity. The inclination allows the 
formation of hydrogen bonds between the carboxylic acid group and the host. The 
cyclodextrin host derivative is therefore capable of recognising the chirality of the guest 
mandelic acid. 
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1.7 Applications of lipophilic cyclodextrins 
The improved ability of modified cyclodextrins to discriminate between enantiomers, 
and their enhanced lipophihcity, has led to their application in a wide variety of 
analytical techniques[60,80]. 
1.7.1 Chromatography 
The use of cyclodextrins in many branches of chromatography has proved to be 
successful. In liquid chromatography modified cyclodextrin bonded stationary phases 
have been demonstrated to be effective at separating enantiomers. Also highly soluble 
modified cyclodextrins have been used as mobile phase additives in reverse phase 
HPLC systems. In gas chromatography both immobilised cyclodextrins, their 
derivatives and cyclodextrin polymers have been used as stationary phases. Alkylated 
cyclodextrins have played a major role in this area of separation'81'821, indeed they have 
acted as enantioselective hosts for the separation of alkene enantiomers ' 7 7 , 8 3 ) (figure 
1.7.1.1). 
OAc OH 
Figure 1.7.1.1 Enantiomeric alkenes studied. 
Cyclodextrins have also become increasingly used in capillary zone electrophoresis, 
either as an additive to the stationary phase'84', or as part of the stationary phase. 
Guttman et al incorporated the cyclodextrin into a polyacryamide gel and this system 
showed an excellent separation of dansylated aminoacids. The ability to separate 
enantiomers was also demonstrated when the aqueous-soluble cyclodextrin 2,6 
dimethyl-p-cyclodextrin was added to the electrolyte background'61'621 of a CZE 
experiment. 
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1.7.2 Cyclodextrins in Electrochemical devices 
The lipophilicity of alkylated cyclodextrins allows them to be included in ion-selective 
electrode membranes. Bates and coworkers1851 used 'poiy'octyi-a-cyciodextrin as an 
ionophore in a sensor for ephedrine. The results showed, unsurprisingly, a difference in 
response of the electrode to the two enantiomers, with the (+) enantiomer being bound 
preferentially, and showing improved slopes and limits of detection. Cyclodextrins 
have also been used in voltammetric experiments, notably in the sub-picomolar 
detection of acetylcholine by Kataky'6 6 1. Most other studies using cyclodextrins in this 
area have been involved in the investigation of their inclusion complexes, and the effect 
these complexes have upon the electrochemical characteristics of the included 
analyte [86]. 
1.8 Investigation of Molecular Recognition by Cyclodextrins 
Cyclodextrins are capable of differentiating between structurally related and 
enantiomeric species. To investigate this phenomenon the techniques of mass 
spectrometry and nuclear magnetic resonance spectroscopy have been widely used. 
1.8.1 Mass Spectrometry 
The development within the last decade of several new ionisation techniques and inlet 
systems has led to an increased number of applications of mass spectrometry. These 
new 'soft' ionisation techniques include electrospray (ES), fast atom bombardment 
(FAB), plasmaspray (PS) and thermospray (TSP). These developments have allowed 
mass spectrometry to be applied to high molecular weight, involatile macromolecules 
such as proteins, enzymes and, of particular interest here, to cyclodextrins. These soft 
methods permit ionisation without high temperatures or high field gradient'871, allowing 
the ionisation of involatile molecules without immediate fragmentation. Hence 
detection of the molecular ion may be undertaken. 
Electrospray soft ionisation technique has been used widely. Here the soft ionisation is 
explained by an ion evaporation mechanism. The sample is sprayed using the high 
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electric field between the capillary and the counter electrode to produce highly charged 
droplets. Desolvation of these droplets either by the drying gas or heat reduces their 
size. At a certain critical size, the repulsion between the charged entities in the droplet 
exceeds the surface tension and ions are emitted. This technique has been used 
successfully for cyclodextrin complexes, for example in characterising the 1:1 
complexes of 2-hydroxypropyl-P-cyclodextrin(881 with the enantiomers of phenylalanine 
methyl ester, propranolol and tryptophan methyl ester. It has also been applied in the 
investigation of the interactions between 2,6 diethanolamine-P-cyclodextrin and the 
drugs glybenclamide and furosemide'891. 
1.8.2 Nuclear Magnetic Resonance 
The majority of cyclodextrin applications require the formation of a complex in 
solution. The application of NMR techniques to the investigation of complexation with 
cyclodextrins and their derivatives is central to the understanding of these structures and 
the dynamics of complexation'90'. 
In 1970 Demarco and Thakkar'911 demonstrated that the aromatic moiety of a guest 
molecule was included within the cyclodextrin cavity. It was observed that the protons 
located on the inner face of the cyclodextrin cavity, H(3) and H(5), were subject to 
anisotropic shielding by the aromatic ring, shifting the resonances to higher frequency. 
The exterior protons were unaffected. 
The advent of Fourier transform NMR and the development of reliable superconducting 
magnets allowed more detailed investigations to be performed. The ful l assignment of 
per-O-methyl-p-cyclodextrin using 2D correlation techniques was published in 1983 [92 ). 
This led to the study of cyclodextrin complexes in the attempt to track down the 
important host-guest interactions which led to recognition. Perly and Djedaini 1 7 0 ' 
applied a variety of high resolution NMR techniques to the investigation of the 
complexes of steroids with (3-cyclodextrins. They showed categorically that p-
cyclodextrins formed true inclusion complexes with steroids such as prednisolane 
because only the chemical shifts of protons located in the hydrophobic cavity were 
affected by complexation. Indeed the study went on to show that the inclusion 
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stoichiometrics and binding constants could be fully rationalised by considering the 
nature and position of substituents on the steroidal skeleton. 
Research by Li and Purdy [ 9 3 ] showed that the substitution pattern on an aromatic moiety 
included within the cavity dictates the guest orientation within the cavity. The 
complexes of ephedrine with a-, P-cyclodextrins and their derivatives have been studied 
in an effort to ascertain the effect of varying the cavity size and alkylation pattern'7 7'8 6 1 
as well as allowing the determination of the binding constants. The investigations 
showed, as expected, that the aromatic moiety was included within the hydrophobic 
cavity, and that any enantiomer discrimination observed was due to the relative 
orientation of the chiral side chain in relation to the secondary hydroxyl rim. This leads 
to discrimination as only one enantiomer is able to form stabilising hydrogen bonds to 
the peripheral hydroxyls of the host. 
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Chapter Two 
Detection of Local Anaesthetics 
2.1 Introduction 
A brief introduction to local anaesthetics is presented (section 2.1.1), followed by the 
methods that have been used to determine the concentration oj local anaesthetics in 
both clinical samples and drug preparation control (section 2.1.2). Section 2.2 contains 
the experimental procedure followed. The results for the local anaesthetics studied are 
presented and discussed in section 2.3. 
2.1.1 Local Anaesthetics 
Local anaesthetics were first used by the Viennese ophthalmologist Carl Koller when he 
used cocaine to produce a reversible corneal anaesthesia by dropping cocaine solution 
into the eye. The use of cocaine as an anaesthetic rapidly spread and within a few years 
was being used widely. However it was not until 1905 that a less dangerous synthetic 
substitute, procaine, was discovered'11. 
Local anaesthetic molecules consist of an aromatic moiety linked via an ester or amide 
group to a basic side chain (except benzocaine, which is considered an atypical local 
anaesthetic, as it has no basic side chain). The molecules are all weak bases with pK a 
values in the range 8 - 9 (lidocaine 8.2, bupivacaine 8.1, the exception is benzocaine 
2.5) so that they are partially ionized at physiological pH. This fact is important as only 
the neutral form can pass through the nerve sheath and axon membrane to reach the 
correct binding site (situated on the inside of the sodium channel) where the protonated 
form binds. Local anaesthetics in plasma are bound by proteins, to a greater or lesser 
extent, and oti-acid glycoprotein is the main protein to which local anaesthetics bind 
(along with other basic drugs). This means that the total drug concentration in plasma 
consists of two forms, 'bound' and 'free'. Such behaviour is similar to the problem of 
'bound and 'free' calcium measurements, where ion-selective electrodes have proven 
well suited to measurement of the 'free' cationic fraction. 
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2.1.1.1 Lidocaine Hydrochloride 
Lidocaine hydrochloride was synthesised in 1943 by Lofgren and was first used in 1948 
as a local anaesthetic. Lidocaine acts as not only an effective local anaesthetic but also 
a class lb antidysrhythmic drug. The normal therapeutic plasma range is 1.0 - 5.0 mg/1 
(4 x 10"6 to 2 x 10"6 mol dm"3), although in some patients concentrations of up to 8.0 
mg/l (2.0 x 10"5 mol dm"3) may be required to prevent ventrical arrhythmias'11. 
The most widely used detection technique is HPLC with an UV detector. 
2.1.1.2 Bupivacaine Hydrochloride 
Bupivacaine hydrochloride is a long acting local anaesthetic and is used for nerve 
blocks in general, including epidural anesthesia and post-surgical pain relief. It is 
administered in the range 1.0 x 10"4 to 7.0 x 10"5 mol dm"3 depending on the type of 
nerve block required. The preferred analytical method is GLC with a nitrogen-
phosphorus detector'21, with a limit of detection of lmg/1 (3 x 10"6 mol dm"3). 
2.1.2 Detection of Local Anaesthetics 
There are many methods used for the detection of local anaesthetics and these can be 
grouped under three main headings, colorimetric, chromatographic (GLC and HPLC) 
and electrochemical. 
2.1.2.1 Colorimetric 
This technique requires the local anaesthetic to have an absorption band separated from 
that produced by any other constituent of the analyte sample. A few colorimetric 
methods for lidocaine have been reported, and one of the more recent was devised by 
Crux et a/.'3] who measured the absorption at 271 nm in illicit drug samples. This 
method has also been used to determine levels of local anaesthetics in pharmaceutical 
preparations. Saleh et a/.'4] described such a method involving the use of haematoxylin 
reagent in the presence of boric acid to give a red-violet chromogen. The method could 
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be applied to many types of preparation. However, the assay time was excessive, being 
in excess of 30 minutes. 
2=1=2=2 Gas Liquid Chromatography (GLC) 
This method has the sensitivity to monitor a large range of drugs in plasma, provided 
the drugs are volatile and thermally stable at temperatures up to 200 °C. Whilst many 
papers have been published on the determination of lidocaine and bupivacaine in 
plasma, they all require a lengthy centrifuge step to extract the analytes into an organic 
phase. This adds considerable time to the analysis. A wide variety of detectors have 
been used in conjunction with the GLC detection of local anaesthetics; flame 
ionisation'51, nitrogen-phosphorus16'71 and surface ionisation detection' 8 , 9 1 0 1 have all been 
described in the literature. By using an appropriate detector with a capillary column to 
provide a high degree of separation, complex mixtures can be separated and individual 
constituents detected. This high degree of separation allows not only the primary 
analyte to be detected but also the drug metabolites that may also be pharmacologically 
active151. Whilst this method does provide high detection limits, it is relatively slow. 
2.1.2.3 High Performance Liquid Chromatography (HPLC) 
As with GLC, a complex mixture of components can be separated based on their 
individual physiochemical properties, and the individual components then eluted and 
detected. Nevertheless, any biological sample still requires pre-treatment to remove 
proteins from the sample as they can accumulate on the separating column and lead to 
clogging and consequently a decrease in chromatographic performance. Many groups 
have worked to develop systems where the biological sample could be injected directly. 
Systems including column switching and specialised packing materials (e.g. the use of 
restricted access reverse phase material) have been developed. One such material 
described by Pinkerton'111, contained a glycolpropyl-bonded surface that was 
nonadsorptive to proteins and a polypeptide phase that would separate the analytes. Yu 
et a/.1121 have combined the ideas of column switching and specialised packing to 
produce a HPLC system for bupivacaine. 
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The most common type of HPLC method uses reverse-phase separation. This has the 
advantage relatively of more rapid separation and analysis of the analyte and its 
metabolites'131 than normal phase separation, due to the weak surface energies of the 
non-polar support and the polar nature of the mobile phase 
Detection by HPLC of lidocaine, bupivacaine and their metabolites has been described 
using mainly T J V 1 1 4 1 3 ' 1 6 1 7 1 , though a voltammetric detector has been used for the 
detection of lidocaine t l 8 ]. Both GLC and HPLC gave similar detection limits of l|ag/ml 
(3.7 x 10 mol dm") for lidocaine and 10 ng/ml (3.7 x 10" mol dm" ) for bupivacaine, 
but analysis times are shorter with HLPC. 
2.1.2.4 Electrochemical Detection 
The use of ISEs as a means of determining levels of clinically relevant analytes has, in 
principle, several advantages over chromatographic methods. The potential advantages 
of using ISEs are their ability to monitor selectively and continuously the levels of a 
particular ion in solution, even whole blood or serum, without the need for a separation 
step. In addition, they have uses in drug quality control where reliable, quick and 
accurate methods are required. 
Several ISEs for both lidocaine[ 1 9 , 2 0 , 2 1 1 and bupivacaine [ 2 2 , 2 3 ] have been fabricated. A l l 
the electrodes produced were based on the ion-pair principle with either lidocaine or 
bupivacaine complexed to a bulky anion in the membrane phase. To date no neutral 
ionophore based systems have been studied. Al l the electrodes produced Nernstian 
gradients. However very few interference studies were carried out, also no protein 
interference effects were studied. The lack of such detailed studies can be explained by 
the authors desire to use these electrode systems for drug preparation control, where the 
drug normally is in an aqueous sample. 
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2.2 Experimental 
The local anaesthetics used in this study were the hydrochloride salts of lidocaine and 
bupivacaine; 
O 
N H O N 
N 
N HC 
H HCl 
Lidocaine Hydrochloride Bupivacaine Hydrochloride 
2.2.1 Lidocaine Hydrochloride 
2.2.1.1 Potentiometric Calibrations 
All measurements were performed using constant volume dilution (section 5.1.2). 
The electroactive membranes used were, 
1) 2,3,6 Trioctyl-P-cyclodextrin (1.2 % ) , oNPOE (65.6 % ) , PVC (32.8 %) and TKB 
(0.4 %) 
2) 2,3,6 Trioctyl-p-cyclodextrin (1.2 % ) , oNPOE (65.6 % ) , Tecoflex SG 80 (32.8 %) 
and TKB (0.4 %) 
The membranes were conditioned in 1 x 10"3 mol dm"3 lidocaine hydrochloride for 12 h 
prior to use. The initial solution was 1 x 10"1 mol dm"3 lidocaine hydrochloride, and the 
diluent solution was de-ionized water. 
Lidocaine hydrochloride was supplied by Sigma (Poole, Dorset, UK). 
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2.2.1.2 Interference Experiments 
Al l measurements were made using continuous volume dilution, the selectivity 
coefficients were determined using the fixed interferent method (section 5.1.3). The 
membranes used were of the same composition as used in the calibration measurements. 
The interferents used in this work were glycine, L-histidine, nicotinamide, vitamin B\, 
and simulated clinical background consisting of 1.45 x 10"1 mol dm"3 sodium chloride, 
4.3 x 10"3 mol dm"3 potassium chloride and 1.26 x 10"3 mol dm"3 calcium chloride. 
The initial solutions consisted of 1 x 10"1 mol d m 3 lidocaine hydrochloride along with 
the interferent. The interferent solutions were; 
1) 'clinical background' 
2) 1x10" mol dm" glycine + 'clinical background' 
3) 1 x 10"2 mol dm"3 nicotinamide hydrochloride + 'clinical background' 
4) 1 x 10" mol dm" nicotinamide hydrochloride + 'clinical background' 
5) 1 x 10"2 mol dm"3 vitamin B] + 'clinical background' 
6) 1 x 10"2 L-histidine + 'clinical background' 
Al l solutions were prepared using de-ionized water. 
o HO O 
H->N 
H 2 
OH NH 
Glycine 
HC 
HO N 
HO 
Nicotinamide Hydrochloride 
OH 
© Adrenalin © ci COOH N 'A H,N// 
H r NH N N 
N 
Vitamin B L-Histidine 
Figure 2.2.1.2. Structures of the organic interferents used in the study. 
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Sodium chloride, potassium chloride and calcium chloride were of analytical grade 
obtained from Merck (Poole, Dorset, UK). Glycine and L-histidine were obtained from 
Sigma (Poole, Dorset, UK), Vitamin Bi and nicotinamide hydrochloride were obtained 
from Fluka (Buchs, Switzerland). 
2.2.1.3 Protein Interference Dip Test 
The membranes used were; 
1) 2,3,6 Trioctyl-p-cyclodextrm (1.2 % ) , PVC (32.8 % ) , oNPOE (65.6 % ) , TKB 
(0.4 % ) . 
2) 2,3,6 Trioctyl-p-cyclodextrin (1.2 % ) , TECOFLEX SG 80 (32.8 % ) , oNPOE 
(65.6 % ) , TKB (0.4 % ) . 
The membranes were mounted as described later. The membrane was conditioned in a 
3 3 
solution of 1 x 10" mol dm" lidocaine hydrochloride and 'clinical background'. 
The experiment was carried out as described in section 5.1.5 
2.2.1.4 Flow Injection Analysis 
2.2.1.4.1 Calibration Experiments 
The membranes used in this section of the work were; 
1) 2,6 Didodecyl-p-cyclodextrin (1.2 % ) , oNPOE (65.6 % ) , PVC (32.8 % ) , and 
KTC1PB (0.4 %) 
2) 2,6 Didodecyl-p-cyclodextrin (1.2 % ) , DOS (65.6 % ) , Tecoflex SG 80 (32.8 % ) , and 
KTC1PB (0.4 %) 
The di-substituted cyclodextrin was used because results obtained by Dr. Ritu Kataky 
had shown that this ionophore led to better electrode response characteristics. The 
electrodes were conditioned in 1 x 10'3 mol dm"3 lidocaine hydrochloride for 12 h prior 
to use. 
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The equipment was set-up as described in section 5.1.4. The carrier solution was 
1 x 10"3 mol dm"3 lidocaine hydrochloride with 1 x 10 1 mol dm"3 sodium chloride. 
The analyte samples were prepared in half decade intervals by serial dilution. 
Al l solutions were made-up using de-ionized water 
2.2.1.4.2 Protein Interference Experiments 
Bovine Serum Albumin (BSA) 
The membranes, carrier solution and reference solution used were the same as in the 
calibration experiments (section 2.2.1.4.1). 
The analyte sample solutions were prepared in the concentration range 1x10"' mol dm"3 
-6 3 
to 1 x 10 mol dm" in half decade intervals by serial dilution. Each sample contained a 
background of 1 x 10"1 mol dm"3 sodium chloride and 40 g/1 BSA (supplied by Sigma, 
Poole, Dorset, UK). 
ai-acid glycoprotein (AAG) 
The membrane used in this study was 2,6 didodecyl-P-cyclodextrin (1.2 % ) , Tecoflex 
SG 80 (32.8 % ) , DOS (65.6 % ) , KTC1PB (0.4 % ) . 
The carrier and the reference solution were the same as in the calibration. The analyte 
sample solutions were prepared in the concentration range 1 x 10"1 mol dm"3 to 1 x 10"6 
mol dm" in half decade intervals by serial dilution. Each sample contained a 
background of 1 x 10"1 mol dm"3 sodium chloride and 0.55 g/1 AAG (supplied by Sigma, 
Poole, Dorset, UK). 
Human Serum 
Blood was taken from willing subjects at Dryburn Hospital (Durham); this was then 
centrifuged leaving serum. No anti-coagulants were added to the serum, as the serum 
was used within 12 h of the blood being taken. 
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The membrane used was 2,6 didodecyl-(3-cyclodextrin (1.2 % ) , Teeoflex SG 80 
(32.8 % ) , DOS (65.6 % ) , KTC1PB (0.4 %) . 
A series of spiked human serum samples were made up by serial dilution these were, 
1 x 10"2, 5 x 10"3, 1 x 10"4, 1 x 10"5, 1 x 10"6, 5 x 10"6 and 1 x 10"7 mol dm"3. The carrier 
solution used was 1 x 10"3 mol dm"3 lidocaine hydrochloride with a simulated 'clinical 
background' (1.45 x 10"1 mol dm' 3 NaCl, 4.3 x 10"3 mol dm"3 KC1 and 1.26 x 10"3 mol 
dm" CaCl2). Before the human serum samples were used a reference curve was 
produced (between 1 x 10"! and 1 x 10"6 mol dm"3) where the lidocaine samples 
contained the 'clinical background'. The human serum samples were injected into the 
system with no washing between injections to remove any adsorbed protein. 
To observe the effects of cleaning the membrane between serum injections two 
experiments were performed on the 1 x 10"2 mol dm"3 lidocaine hydrochloride/human 
serum sample; 
1) Injection of the serum samples with no attempt to wash between injections. 
2) Between analyte injections, a Pepsin solution (5 % pepsin in 0.1 x 10"' mol dm"3 
Hydrochloric acid) was injected through the sample loop and into the detector cell. 
2.2.2 Bupivacaine Hydrochloride 
2.2.2.1 Potentiometric Calibrations 
All measurements were performed using constant volume dilution. 
The electroactive membranes used were; 
1) 2,3,6 Trioctyl-p-cyclodextrin (1.2 % ) , oNPOE (65.6 % ) , PVC (32.8 %) and TKB 
(0.4 %) 
2) 2,3,6 Trioctyl-p-cyclodextnn (1.2 % ) , oNPOE (65.6 % ) , Tecoflex SG 80 (32.8 %) 
and TKB (0.4 %) 
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The membranes were conditioned in 1 x 10"3 mol dm"3 bupivacaine hydrochloride for 12 
h prior to use. The initial solution was 1 x 10"' mol dm" bupivacaine hydrochloride, 
and the diluent solution was de-ionized water. 
The bupivacaine hydrochloride was supplied by Sigma (Poole, Dorset, UK). 
2.2.2.2 Interference Experiments 
Al l measurements were made using the continuous volume dilution, the selectivity 
coefficients were determined using the fixed interferent method (section 5.1.3). The 
membranes used were of the same composition as used in the calibration measurements. 
The interferents used in this work were glycine, L-histidine, nicotinamide, vitamin Bi , 
adrenaline, and simulated 'clinical background'. The simulated 'clinical background' 
consisting of 1.45 x 10"1 mol dm"3 sodium chloride, 4.3 x 10"3 mol dm"3 potassium 
chloride and 1.26 x 10"3 mol dm"3 calcium chloride. 
The initial solutions consisted of 1 x 10"2 mol d m 3 bupivacaine hydrochloride along 
with the interferent. The interferent solutions were; 
1) 'clinical background' 
2) 1 x 10"2 mol dm"3 glycine + 'clinical background' 
3) 1 x 10"2 mol dm"3 nicotinamide hydrochloride + 'clinical background' 
4) 1 x 10"3 mol dm"3 nicotinamide hydrochloride + 'clinical background' 
5) 1 x 10"2 mol dm"3 vitamin Bi + 'clinical background' 
6) 1 x 10"2 L-histidine + 'clinical background' 
7) 2.7 x 10"2 mol dm"3 adrenaline + 'clinical background' 
Al l the solutions were prepared using de-ionized water. 
Sodium chloride, potassium chloride and calcium chloride were of analytical grade 
obtained from Merck (Poole, Dorset, UK). Glycine, L-histidine and adrenaline were 
obtained from Sigma (Poole, Dorset, UK), Vitamin Bi and nicotinamide hydrochloride 
were obtained from Fluka (Buchs, Switzerland). 
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2.2.2.3 Protein Interference Dip Test 
The membranes used were; 
3) 2,3,6 Tnoctyl-p-cyclodextrin (1.2 % ) , PVC (32.8 % ) , oNPOE (65.6 % ) , TKB 
(0.4 %) . 
4) 2,3,6 Trioctyl-P-cyclodextrin (1.2 % ) , TECOFLEX SG 80 (32.8 % ) , oNPOE 
(65.6 % ) , TKB (0.4 % ) . 
The membranes were mounted as described earlier. The membrane was conditioned in 
3 3 
a solution of 1 x 10" mol dm" bupivacaine hydrochloride and 'clinical background'. 
The experiment was carried out as described in section 5.1.5. 
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2.3 Results and Discussion 
2.3.1 Lidocaine Hydrochloride 
2.3.1.1 Potentiometric Calibrations 
Initially in order to identify the most suitable functionalized cyclodextrin for use in ion-
selective electrodes for this class of compounds, lipophilic a-, (3- and y-cyclodextrins 
were evaluated as ionophores in potentiometric sensors for procaine hydrochloride. 
2,3,6 Trioctyl-a-cyclodextrin gave no response to the ion. 2,6 dioctyl-y-cyclodextrin 
showed a sub Nernstian response, with a slope of only 42.5 mV/decade. Use of 
2,6 didodecyl-P-cyclodextrin gave rise to only a slightly sub-Nernstian response (slope 
50.0 mV/decade), which improved to an ideal Nernstian response in the presence of a 
simulated 'clinical background' of cations'241. 
Following on from this work it was decided to investigate further the response to 
lidocaine hydrochloride using 2,3,6 trioctyl-f5-cyclodextrin as the ionophore. 
In addition the effect of using TECOFLEX SG 80 as the membrane matrix instead of 
PVC was evaluated. Such a study was of direct interest in assessing the suitability of 
each matrix in the assay of serum samples. In blood or serum samples there are usually 
problems with protein interference. Polyurethanes (e.g. TECOFLEX) have been used 
by several research groups in an attempt to reduce the shift in the measured potential 
due to the non-specific adsorption of proteins on the membrane surface'25'261. Therefore, 
it was of interest to study the electrode response when TECOFLEX was used as the 
matrix in the calibration experiments. 
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Figure. 2.3.1.1.1 Lidocaine Calibrations using both PVC and TECOFLEX membrane 
matrices at 298 K. 
The results from the calibration in deionized water (Figure 2.3.1.1.1 and Table 
2.3.1.1.1) show the response characteristics of the 2,3,6 trioctyl-P-cyclodextrin based 
electrodes. The results using a PVC matrix showed an excellent Nernstian gradient, 
while using the TECOFLEX polymer the response was slightly sub-Nernstian at 298 K. 
Membrane Matrix Gradient (mV/decade) Limit of detection 
(mol dm"3) 
PVC 59.1 1.6 x 10"4 
TECOFLEX SG 80 54.2 8.7 x 10* 
Table. 2.3.1.1.1. Calibration data. Each membrane contains 2,3,6 trioctyl-P-
cyclodextrin, oNPOE and TKB. 
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The results obtained from the calibrations are comparable with those obtained by 
various other groups'1 8'1 9 2 0 2 1 1 . However, as mentioned earlier, these electrodes were all 
based on an ion-pair membrane system, so that these lipophilic cyclodextrin-based 
sensors were the first neutral ionophores used for the detection of lidocaine. 
2.3.1.2 Potentiometric Interferent Studies 
The interference effect of various cationic species found in serum was studied (Figures 
2.3.1.2.1 and 2.3.1.2.2). The simulated 'clinical background' contained 1.45 x 10"1 
mol dm"3 NaCl, 4.3 x 10"3 mol dm"3 KC1 and 1.26 x 10"3 mol dm"3 CaCl2. The 
concentrations of these ions were chosen to fall within the normal physiological range 
observed. The other interferents used, glycine (1.46 x 10"4 - 3.52 x 10"4 mol dm"3), 
histidine (7.3 x 10"5 - 1.25 x 10"4 mol dm"3), vitamin Bj (1.2 x 10"8 - 5.9 x 10"8 
mol dm"3) and nicotinamide (3.3 x 10"5 - 7.4 x 10"5 mol dm"3) were all chosen to allow 
comparison between this study and others performed on the same analyte. The 
physiological ranges for these compounds are given in brackets. The concentration 
2 3 3 
chosen for these interferents was arbitrarily set at 1 x 10" or 1 x 10" mol dm", 
depending upon the solubility of the interferent. 
In the presence of a simulated 'clinical background' of Na +, K + and Ca 2 + the responses 
of both electrodes were Nernstian with good selectivity coefficients ( - log Kj*", overall 
~ 3.0), and good limits of detection (-Log [Lidocaine] > 3.3). This is consistent with 
what is known about cyclodextrins, i.e. that the hydrophobic nature of the cyclodextrin 
cavity wil l include the aryl moiety and/or the amine portion of the lidocaine preventing 
any interference from the hydrophilic alkali and alkaline earth cations'2 7 , 2 8'. 
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Figure 2.3.1.3.1. Response Curves for Calibration and interferents for the PVC 
2 3 
membrane. A: aqueous, B: clinical Interference; C: 1 x 10" mol dm" Glycine; D: 1 
10"3 mol dm"3 Nicotinamide; E: 1 x 10"2 mol dm"3 Vitamin B i ; F: 1 x 10"2 mol dm"3 L 
histidine. 
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Membrane 
Matrix 
Interferent Gradient 
(mV/ decade) 
Limit of 
detection 
(mol dm"3) 
- Log K~ 
PVC 
'clinical 
background' 
58.0 6.5 x 10"5 4.0 
Vitamin Bi 56.4 3.6 xlO" 4 2.4 
L-histidine 41.7 9.1 xlO" 4 2.0 
T E C O F L E X 
'clinical 
background' 
55.7 4.8 x 10"4 2.5 
Vitamin B t 56.8 7.6 x 10"4 2.1 
L-histidine 67.4 3.6 x 10"3 1.4 
Table 2.3.1.2.1. Potentiometric results for lidocaine detection in the presence of cationic 
interferent species. 
The interference from various cationic organic species on the electrode response was 
studied for lidocaine (table 2.3.1.2.1). Selectivity coefficients were calculated for 
vitamin B] and L-histidine. These two molecules have pK a values of 4.8 and 9.2 (for 
vitamin Bi), and 2.2, 6.17 and 9.28 (for L-histidine) and hence are ionic at the 
physiological pH (pH 7.4) and at the pH of the analyte solutions pH ~ 6.0). For the 
other organic interferents used i.e. glycine, nicotinamide and adrenaline (relevant pK„ 
values > 8) selectivity coefficients were not calculated as the organic interferent was not 
ionic at the pH the investigations were performed at. The interferents are primarily non-
ionic at physiological pH, so that any effect on the electrode response would be due to 
blockage of the ionophore or electrode fouling rather than any competition between the 
interferent and lidocaine for charge induced membrane transport. 
The major interferent for lidocaine was L-histidine which reduced the slope of the PVC 
electrode to 41.7 mV/decade (limit of detection 9.1 x 10"4 mol dm"3). With the 
TECOFLEX membrane an increase in the slope to 67.4 mV/decade was observed (limit 
of detection 3.6 x 10"3 mol dm"3). Nicotinamide also interfered, and produced a 
continuous base line drift for 2 to 3 h. The drift was not evident when the concentration 
of nicotinamide background was reduced to 1 x 10"3 mol dm"3. 
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Figure 2.3.1.3.2. Response Curves for Calibration and interferents for the TECOFLEX 
SG 80 membrane. A: aqueous, B: clinical Interference; C: 1 x 10"2 mol dm"3 Glycine; 
D: 1 x 10"3 mol dm"3 Nicotinamide; E: 1 x 10"2 mol dm"3 Vitamin B,; F: 1 x 10"2 mol 
dm"3 L-histidine. 
The results from the interference experiments indicate that the major interferents are 
those molecules of similar size and structure to the primary analyte i.e. L-histidine and 
nicotinamide. The interaction of lidocaine with the cyclodextrin is probably via 
inclusion of the aryl moiety with hydrogen bonding interactions between either the 
protonated amino group or the amido - N H with the glycosidic oxygen or the ether 
oxygens on the side chains. Given such a mode of binding between lidocaine and the 
cyclodextrin it is not surprising that the major interferents were aryl species with 
pendant amide or amine groups. However the physiological levels of these interferents 
is considerably lower than used in the interference studies, 7.3 x 10"5 - 1.25 x 10"4 mol 
dm"3 and 3.3 x 10"5 - 7.4 x 10"5 mol dm"3 respectively for histidine and nicotinamide. 
Therefore in a clinical situation the interference for these molecules can be expected to 
be significantly lower. 
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2.3.1.3 Protein Interference 
The effect of switching PVC and TECOFLEX based lidocaine selective electrodes 
between the aqueous electrolyte (containing simulated 'clinical background') and the 
electrolyte solution (which contained added protein) produced three sets of data. These 
corresponded to the presence of Bovine serum albumin (BSA), ai-acid glycoprotein 
(AAG) and Pooled human serum (HS) respectively as described previously in section 
5.1.5. Each of the three data sets comprises two further sets of data, corresponding to 
aqueous and protein containing solutions for the PVC and TECOFLEX membranes. 
2.3.1.3.1 Bovine Serum Albumin (BSA) Interference 
After the initial exposure to BSA, the recorded potential dropped (Figure. 2.3.1.3.1.1. 
pts 1 and 2) for both the PVC- and TECOFLEX-based electrodes. 
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Figure 2.3.1.3.1.1. The potentiometric response for both PVC and TECOFLEX based 
membrane electrodes in the presence of 40 g/1 BSA. 
After this initial exposure to BSA, the TECOFLEX membrane returned to its original 
^•Intemai value in the aqueous sample (containing simulated 'clinical background'). This 
result is consistent with the results obtained by other groups, which have shown that 
50 
TECOFLEX-based membranes produce a small, reproducible "asymmetry potential" 
for calcium ion-selective electrodes'25'261. 
The PVC-based membrane however did not show the same reproducibility in its 
ELemai values after exposure to the BSA. Indeed the results showed a degree of scatter. 
Again, this is consistent with work published on calcium ion-selective electrodes by 
Simon'2 9 1 and D'Orazio'2 5 1. 
2.3.1.3.2 Interference from oti-acid glycoprotein (AAG) 
Drugs in whole blood and serum are well known to bind to proteins. This protein 
binding can be extensive and the relevant proportions of bound drug can have profound 
effects on the therapeutic availability of the drug in the body, as only the free fraction 
may cross biological membranes'301. The most common of the plasma proteins to bind 
drugs are albumin and oci-acid glycoprotein (the so called acute phase or 'stress' 
protein). On the whole it is the more acidic drugs (e.g. barbiturates) that bind to 
albumin, while basic drugs (e.g. local anaesthetics) bind to AAG' 3 1 1 . With 
approximately 65 % of lidocaine being bound by AAG, this percentage can increase as 
the concentration of AAG present in serum increases, for example after surgery or 
myocardial infarction. 
The measurements performed used 0.55 g/1 AAG in a 'clinical background' of Na +, K + 
and Ca . The results show (Figure 2.3.1.3.2.1) that the effect of AAG on inducing a 
shift in the E°intemal was very small for both electrodes at the concentrations of analyte 
and AAG used. 
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Figure 2.3.1.3.2.1. Potentiometric Response for both PVC and TECOFLEX based 
membranes with ai-acid glycoprotein interference. 
2.3.1.3.3 Pooled Human Serum (HS) Interference 
Since one use o f this sensor was to be to monitor levels o f lidocaine in serum, this 
experiment was carried out to observe the shift in potential induced by pooled human 
serum. 
The results obtained (Figure. 2.3.1.3.3.1) show a similar trend to that observed for the 
BSA interference. The main difference was that the induced E°intemal shift when the 
electrodes were transferred between the aqueous and protein based solution 
(approximately 20 m V ) was larger than was observed in the presence o f B S A only 
(approximately 8 mV) . 
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Figure 2.3.1.3.3.1. Potentiometric Results for both PVC and TECOFLEX based ISEs 
wi th pooled human serum. 
2.3.1.4 Flow Injection Analysis 
The experimental work was performed using the equipment described in section 5.1.4. 
Most routine determinations o f clinical analytes are performed using this technique due 
to its inherent advantages o f a high sample throughput and the ease o f automation. 
The results are broken down into two sections, the first section relates to the calibration 
experiments. Three membranes were studied to examine the effect o f membrane matrix 
material (PVC or TECOFLEX) and plasticizer (oNPOE or DOS). The second section 
was concerned with the effect o f protein on the response curves for lidocaine. It was 
envisaged that protein interference would be reduced compared with the dip-test method 
due to the short contact time between the protein-containing sample and the ion-sensing 
membrane. This has been the case for both work on both potassium [ 3 2 ] and calcium' 2 6 1 
which has been published, and in each case, the protein interference effect was shown to 
be small. 
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2.3.1.4.1 F I A Calibration 
The electrode characteristics o f three electroactive membranes were compared: 
1. 2,6 Didodecyl-p-cyclodextrin, PVC, oNPOE, KTC1PB 
2. 2,6 Didodecyl-P-cyclodextrin, TECOFLEX SG 80, oNPOE, KTC1PB 
3. 2,6 Didodecyl-p-cyclodextrin, TECOFLEX SG 80, DOS, KTC1PB 
A comparison o f the calibration and interference results for both 2,3,6 trioctyl-P-
cyclodextrin and 2,6 didodecyl-P-cyclodextrin showed that the 2,6 didodecyl-P-
cyclodextrin gave the better response to lidocaine. In the calibration curves shown 
below, the average peak heights for each concentration point are the average o f the peak 
to baseline potential for at least f ive successive injections o f analyte solution. 
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Carrier: 1 x l O 3 mol dm - 3 lidocaine, 1 x l O 1 mol dm - 3 NaCl 
Ref. Solution: 1 x l O ' mol dm-3 KC1 
Flow Rate: 0.06 ml s"1 
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Figure 2.3.1.4.1a. Calibration with PVC based membrane. 
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Reference Solution: 1 x l O 1 mol dm-3 K G 
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Figure 2.3.1.4. lb . Calibration using TECOFLEX, oNPOE based membrane. 
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Figure 2.3.1.4.1c. Calibration using TECOFLEX, DOS based membrane. 
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Figure 2.3.1.4. I d Comparison o f response traces for an analyte sample o f 1 x 10 
mol dm*3 lidocaine. 
The results f rom the calibrations are illustrated in Figures 2.3.1.4.1a, b, and c. The 
TECOFLEX-based membranes produced Nemstian gradients, whereas the PVC-based 
membrane was slightly sub-Nernstian in its response whilst the DOS based membrane 
appeared to give the most stable baseline and consistent peak height. O f the three 
membranes studied the TECOFLEX-oNPOE was the most sensitive towards the analyte 
(figure 2.3.1.4. Id) . However, the peak-response was not ideal and a tailing o f the peak 
and dr i f t in the baseline was observed. The tailing produced meant that i f this 
membrane was to be used in an FIA analyser for lidocaine, the time between injections 
would have to be longer. 
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2.3.1.4.2 F I A studies of Protein Interference 
2.3.1.4.2.1 Effect of BSA Interference 
Tecoflex, DOS membrane in 40 g/L BSA 
0.3 Gradient: 59.7 mV/decade 
PVC, oNPOE membrane in 40 g/L BSA 
Gradient: 
0.2 
0.1 
OJj 
J — 
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Figure 2.3.1.4.2.1a BSA interference on PVC and TECOFLEX membranes. 
Both the PVC and TECOFLEX membranes were tested with analyte solutions 
containing 40 g/1 BSA and the results are shown in figure 2.3.1.4.2.1a. These 
experiments showed that the TECOFLEX membrane maintained the Nernstian response 
in the presence o f protein, whilst the PVC-based electrode produced a non-Nernstian 
response curve. Figure 2.3.1.4.2.1b shows the response traces both for PVC and 
TECOFLEX based membranes in the presence o f 40 g/1 BSA, the analyte concentration 
was 5 x 10"4 mol dm"3 lidocaine. The figure clearly shows the instability o f the PVC 
baseline, and irreproducibility o f the peak height. 
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Figure 2.3.1.4.2b. Comparison o f PVC and TECOFLEX based ISEs towards an analyte 
solution o f 5 x 10"4 mol dm"3 lidocaine with 40 g/1 BSA. 
It was also o f interest to study the variation o f the recorded potential with time. Such a 
dr i f t in the baseline or variation in the peak height would indicate that the protein 
present in the samples may be inducing an 'asymmetry potential'. A comparison 
between the response traces for 1 x 10"4 mol dm"3 lidocaine with and without BSA is 
given in figure 2.3.1.4.2.1c. 
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Figure 2.3.1.4.2.1c. Comparison o f the response traces for 1 x 10"4 mol dm"3 lidocaine 
and 1 x 10"4 mol d m 3 lidocaine, 40 g/1 BSA, both in a background o f 1 x 10"1 mol dm"3 
NaCl. Membrane composition: 2,6 Didodecyl-P-cyclodextrin, TECOFLEX, DOS, 
KTC1PB. 
This study shows clearly that upon each injection o f the BSA containing sample there 
was no variation in the baseline or peak potential caused by protein adsorption onto the 
membrane. 
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2.3.1.4.2.2 Interference from aj-acid glycoprotein 
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Figure 2.3.1.4.2.2a. Response to lidocaine in the presence o f 0.55 g/1 A A G , compared 
with the calibration response. 
The effects o f cti-acid glycoprotein on the response o f the TECOFLEX-DOS-based 
membrane were investigated. Figure 2.3.1.4.2.2a shows a comparison between the 
response curves for the calibration and solutions containing 0.55 g/1 A A G . The gradient 
is only reduced slightly (55.4 mV/decade f rom 57.7 mV/decade). 
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Figure 2.3.1.4.2.2b Comparison o f lidocaine response in the presence o f BSA and A A G . 
A comparison was then made between the response curves for analyte solutions 
containing 40g/l BSA and 0.55 g/1 A A G . Both types o f protein had little effect on the 
electrode as the electrode was able to maintain a Nernstian response (calibration 
gradient: 57.7 mV/decade, BSA interference gradient: 59.4 mV/decade, A A G 
interference gradient: 55.4 mV/decade). Furthermore, the electrodes in both BSA and 
A A G solutions produced a steady baseline (figure 2.3.1.4.2.2c), wi th no dr i f t evident, 
implying that the protein was not 'adhering' to the electrode surface and hence not 
inducing a membrane 'asymmetry potential'. 
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Figure 2.3.1.4.2.2c Comparison o f responses for an analyte sample o f 1 x 10"4 mol dm"3 
lidocaine with BSA and A A G . 
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2.3.1.4.2.3 Effect of Human Serum 
Samples o f human serum were obtained f rom healthy adult volunteers - including the 
author. Before the doped human serum samples were injected into the FIA, a response 
curve was produced using lidocaine samples containing a simulated 'clinical 
background' (i.e. containing 1.45 x 10"1 mol dm"3 NaCl, 4.6 x 10"3 mol dm"3 KC1 and 
1.26 x 10"3 mol dm"3 CaCl 2). The 'clinical background' was added to the initial 
solutions as i t may be considered as a simple calibration matrix for the blood serum 
samples. The resulting response curve can be considered a simple reference curve 
similar to those commonly used in clinical analysis, to which response o f the doped 
human serum samples can be compared. However, the reference solutions only 
contained sodium, potassium and calcium, and did not, as more complex analytical 
reference solutions do, correct for pH, ionic strength and protein content' 3 3 ' 3 4 1. 
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Figure 2.3.1.4.2.3a. A response curve for lidocaine solutions in presence o f simulated 
'clinical background' and doped human serum samples. 
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The response in the presence o f the simulated 'clinical background' gave an excellent 
gradient (58.6 mV/decade) with a good overall selectivity coefficient (-log K f i ^ ) c l i n = 
2.7, overall) showing again that charge dense cations do not interfere wi th the response 
of the electrode. As can be seen from figure 2.3.1.4.2.3a the response o f each doped 
human serum sample is offset f rom the calibration curve by 13 ± 3 mV. This suggests 
that the 'calibration matrix' is not ideal and that a more realistic calibration solution 
should be used. The offset was probably due to a protein induced 'asymmetry 
potential'. 
1 x 10"5 mol dm-3 lidocaine, Clinical background 
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Figure 2.3.1.4.2.3b. Comparison between responses obtained for 1 x 10~5 mol dm"3 
lidocaine in a background o f simulated 'clinical background' and in human serum. 
This is consistent with the results obtained f rom the dip-test protein studies discussed 
earlier. These dip-test results also showed that the asymmetry is greater than that 
observed with BSA alone (see figure 2.3.1.4.2.3c). Therefore, in addition to the 
albumin some other serum constituent is also affecting the results. 
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The results shown in figure 2.3.1.4.2.3b are the responses for solutions o f 1 x 10" 
mol d m 3 lidocaine with either a background o f 'clinical cations' or in human serum. 
The figure shows that, although the peak to baseline potential remained constant, the 
baseline was drifting. 
As the electrodes were adsorbing proteins f rom the serum samples, the effect o f 
washing the system through with a solution known to remove protein f rom electrodes 
was investigated. A 5% solution o f pepsin in 0.1 M hydrochloric acid was used for this 
purpose. The pepsin solution was injected alternately wi th the human serum samples. 
The effect o f using the pepsin solution is shown in figure 2.3.1.4.2.3d. The pepsin 
solution appeared to have a significant effect in reducing the drif t in the baseline, which 
is most easily seen by comparison with the response curve when the system was not 
washed wi th the pepsin solution. 
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Figure 2.3.1.4.2.3c. Comparison o f the Response curves for the calibration solutions and 
those containing 40 g/1 BSA. 
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Figure 2.3.1 4.2.3d. Traces for 1 x 10"2 mol dm"3 lidocaine in human serum, with and 
without washing between injections wi th pepsin solution. 
66 
2.3.2 Bupivacaine Hydrochloride 
2.3.2.1 Potentiometric Calibrations 
The results f rom the calibrations in deionized water are shown in Figure 2,3.2.1.1 and 
Table 2.3.2.1.1. They reveal that both electrodes showed Nerastian response to 
bupivacaine, and gave excellent limits o f detection. 
The results compare favourably wi th those obtained by Shoukry et alP2\ whose sensor 
was based on ion-pair formation between tetraphenylborate ions and bupivacaine 
cations in a PVC membrane. This electrode showed a Nernstian response 
(58.2 mV/decade) and a detection l imit o f 2 x 10"4 mol dm"3. 
250 2,3,6 tnoctyl-B-cyclodextnn, PVC, 
oNPOE, T K B 
2,3,6 tnoctyl-B-cvclodextnn, T E C O F L E X , 
oNPOE, T K B 
200 Theoretical Nernstian Gradient 
> 150 
100 
50 
i i 
Log [Bupivacaine] 
Figure 2.3.2.1.1 Bupivacaine Calibration performed at 298 K. Comparison o f 
TEOFLEX- and PVC-based membranes. 
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Membrane Matrix Gradient (mV/ decade) Limit of Detection 
(mol dm' 3) 
PVC 57.2 1.2 x 10"5 
TECOFLFX SG 80 56.5 4.9 x 10"5 
Table 2.3.2.1.1. Calibration Data. Each membrane contains 2,3,6 trioctyl-P-
cyclodextrin, oNPOE and TKB. 
2.3.2.2 Interferent Experiments 
The interference effect of various cationic species found in serum was studied (Figures 
2.3.2.2.1, 2.3.2.2.2 and table 2.3.2.2.1), by examining the response characteristics of 
both PVC and TECOFLEX based bupivacaine sensitive electrodes. The simulated 
'clinical background' contained 1.45 x 10"1 mol dm"3 NaCl, 4.3 x 10"3 mol dm"3 KC1 and 
3 3 
1.26 x 10" mol dm" CaC^. The concentration values, as before, were all chosen to fall 
within the normal physiological range observed for these ions. The other interferents 
used, glycine (1.46 x 10"4 - 3.52 x 10"4 mol dm"3), histidine (7.3 x 10"5 - 1.25 x 10"4 
mol dm"3), vitamin B] (1.2 x 10"8 - 5.9 x 10"8 mol dm"3), nicotinamide (3.3 x 10"5 - 7.4 x 
10"5 mol dm"3) and adrenaline (2.7 x 10"6 mol dm"3) were all chosen to allow comparison 
between this study and others performed on the same analyte. The physiological ranges 
for these compounds are given in brackets. With the exception of adrenaline, the 
concentration shown is that routinely used in bupivacaine injections. The concentration 
chosen for these interferents was arbitrarily set at 1 x 10"2 or 1 x 10"3, mol dm"3 
depending upon the solubility of the interferent. 
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A: Calibration 
B: Simulation 'clinical background' 
C: Glycine 
250 D: Nicotinamide (1 x 10 2 mol dnr 3) 
E: Nicotinamide (1 x l O 3 mol dm-3) 
F: L-histidnie 
200 G: Adrenaline 
Theoretical Nernstian Gradient 
§ , 150 
& 100 
50 
i 1 i i i i i i i 
2 3 4 5 6 
-Log [Bupivacaine] 
Figure 2.3.2.2.1. Response Curves for Calibration and interferents for the PVC 
membrane. A: aqueous, B: clinical Interference; C: 1 x 10"2 mol dm"3 Glycine; D: 1 x 
10"3 mol dm"3 Nicotinamide; E: 1 x 10"3 mol dm"3 Nicotinamide; F: 1 x 10"2 mol dm"3 L-
histidine; G: 2.7 x 10"6 mol dm"3 Adrenaline. 
In the simulated 'clinical background' the response from both the electrodes was 
maintained. As before excellent selectivity coefficients (-Log Kj}°', overall > 4) were 
observed, with very good limits of detection and slopes. 
With the 'organic' interferents, selectivity coefficients were only calculated for the 
solution of L-histidine in 'clinical background' as this was the only interferent that was 
ionic at the pH used (pH ~ 6). Any interference from the other molecules would have to 
arise from blockage of the ionophore cavity or electrode fouling. 
The results show that major interferents for bupivacaine were nicotinamide and vitamin 
Bi . Since neither of the interferents are charged at the pH in question the interference 
cannot occur though competition between the analyte and these interferents for charge 
induced membrane transport. The interference is probably due to the vitamin Bi and 
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nicotinamide hindering the uptake of bupivacaine by blocking the cyclodextrin cavity. 
However, the physiological levels of these interferents are considerably lower than 
those used in the interference studies (3.3 x 10"5 - 7.4 x 10"5 and 1.2 x 10"8 - 5.9 x 10"8 
mol dm"3 respectively for nicotinamide and vitamin Bi). Therefore in a clinical 
situation the interference from these molecules can be expected to be significantly 
lower. 
Membrane 
Matrix 
Interferent Gradient 
(mVdecade) 
Limit of 
Detection 
(mol dm"3) 
-Log K f 
PVC 'Clinical 
background' 
53.9 1.6 xlO" 5 4.0 
L-histidine 60.4 6.0 x 10'5 2.8 
T E C O F L E X 'Clinical 
background' 
56.3 1.9 x 10"5 3.9 
L-histidine 61.7 2.1 x 10"4 2.7 
Table 2.3.2.2.1. Potentiometric results for bupivacaine detection in the presence of 
cationic interferent species. 
The effect of the interferents upon the response of the electrodes studied was less 
pronounced than that reported previously by other groups'221. The use of an alkylated 
cyclodextrin has also reduced the interference from the charge dense cations of Na + and 
K + compared with those from the ion-pair electrode (- Log K?°'pNa+ = 1.6, 
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A: Calibration 
240 B: Simulated clinical background1 
C: Glycine 
D; Nicotinamide (1 x l O 2 mol dm-3) 
E: Nicotinamide (1 x K H mol dm-3) 200 
F: L-histidine 
180 Theoretical Nernstian Gradient 
B 160 
H 140 
120 
100 
80 
60 
-Log [Bupivacaine] 
Figure 2.3.2.2.2. Response Curves for Calibration and interferents for the TECOFLEX 
membrane. A: aqueous, B: clinical Interference; C: 1 x 10"2 mol dm"3 Glycine; D: 1 x 
10"3 mol dm"3 Nicotinamide; E: 1 x 10"3 mol dm"3 Nicotinamide; F: 1 x 10"2 mol dm"3 
L-histidine. 
2.3.2.3 Protein Interference 
Switching the PVC and TECOFLEX based bupivacaine selective electrodes between 
the aqueous electrolyte (containing the simulated 'clinical background') and an 
electrolyte solution containing added protein produced three sets of data. These sets 
corresponded to the presence of bovine serum albumin (40 g/1), ai-acid glycoprotein 
(0.55 g/1) and pooled human serum respectively as described in section 5.1.5. Each of 
the three data sets comprised two further sets of data, corresponding to aqueous and 
protein containing solutions for the PVC and TECOFLEX membranes. 
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2.3.2.3.1 Effect of Bovine Serum Albumin 
For both the PVC and TECOFLEX based membranes, an initial drop in potential was 
observed after the first exposure of the membranes to protein (pts 1 and 2 in Figure. 
2.3.2.3.1.1). After this initial exposure to protein, the TECOFLEX-based membrane (in 
the aqueous solutions containing simulated 'clinical background') returned to its 
original E°mternal potential. Each successive exposure to the protein led to a small and 
reproducible protein induced shift (asymmetry potential 6 mV). The PVC based 
electrode however showed a varying protein induced potential shift, the magnitude of 
which was highly variable, 8+3 mV. 
Bup /Clin. 
PVC 
Bup /BSA 
PVC 
Bup/ Clin. 
TECO 
Bup /BSA 
TECO 
0 40 80 120 160 200 240 280 320 360 400 
Time /min 
Figure 2.3.2.3.1.1. Potential Response results for both PVC and TECOFLEX based 
bupivacaine selective electrodes with bovine serum albumin interference. 
These results are consistent with those reported by D'Orazio [ 2 4 ] who has compared the 
response characteristics of PVC- and TECOFLEX-based calcium electrodes. His work 
showed that the protein induced "asymmetry potential" was much smaller and more 
reproducible for a TECOFLEX-based ion-selective electrode than a PVC one. 
Since it is known that basic drugs, like bupivacaine, do not bind albumin, it is likely that 
any potential differences between the results for the aqueous and the protein containing 
solution must be due to the nature of the matrix material. 
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220 
200 
2.3.2.3.2 Interference Effect of ai-acid glycoprotein 
The protein to which basic drugs, such as bupivacaine, bind is a i-acid glycoprotein. An 
experiment was performed to observe i f any difference in potential could be observed 
due to protein binding of the analyte, bupivacaine. The results from this experiment are 
illustrated in Figure 2.3.2.3.2.1. 
270 
40 80 120 160 200 240 280 320 360 400 
Time /min 
Bup /Clin. 
PVC 
Bup /AAG 
PVC 
Bup / Clin. 
TECO 
Bup /AAG 
TECO 
Figure 2.3.2.3.2.1. Potential Response for PVC and TECOFLEX based bupivacaine 
selective electrodes with ai-acid glycoprotein Interference. 
Both the PVC and TECOFLEX based membranes gave rise a shift in E°in1emal values, 
after each successive exposure to the ai-acid glycoprotein. The effect was more 
pronounced for the PVC membrane. This systematic shift in the E°MeTlwll for the PVC 
electrode is again probably due to protein adsorption on the electrode. PVC has a less 
polar surface than TECOFLEX so it is more prone to protein binding than TECOFLEX. 
Protein binding to the PVC surface may cause an increase in the apparent resistance of 
the system and therefore affect the measured potential. The lack of any change in the 
TECOFLEX potential suggests that this protein was not binding to the surface. 
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2.3.2.3.3 Potential Response Effect of Pooled Human Serum 
A similar trend to that found for BSA interference was observed (figure 2.3.2.3.3.1). 
The TECOFLEX-based membrane consistently returned to its initial E°Memal after each 
exposure to the protein solution, although the induced "asymmetry potential" was larger 
(asymmetry potential - human serum: 20 mV, bovine serum albumin: 6 mV). With the 
PVC electrode, the results again revealed a scatter in the ElteTnal recovery after protein 
exposure and again the "asymmetry potential" was larger. In each case the larger 
"asymmetry potential" is probably due to the strong binding of bupivacaine with the 
plasma proteins (though not with albumin)'3 5 1. This stronger binding is due to its 
lipophilicity, (distribution coefficient, octanol/water, log PBuPivacaine: 2.5, log Procaine: 
0.6) which is significantly higher than that of lidocaine. 
220 
120 
0 40 80 120 160 200 240 280 320 360 400 
Time /min 
Bup /Clin. 
PVC 
Bup /SERUM 
PVC 
Bup / Clin. 
TECO 
Bup /SERUM 
TECO 
Figure 2.3.2.3.3.1. Potential Response for PVC and TECOFLEX based bupivacaine 
selective electrodes with pooled human serum interference. 
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2.3.3 Summary 
Host guest complexation between cyclodextrins and local anaesthetics has been studied 
previously1 3 6'3 7 1. The cyclodextrin derivatives 2,6 didodecyl- and 2,3,6 tnoctyl-|3-
cyclodextrin were the first neutral ionophores reported for local anaesthetics. The study 
performed showed that they may be used as ionophores for the hydrochlorides of local 
anaesthetics. Electrode response parameters were maintained in the presence of serum 
levels of Na +, K + and Ca 2 + and several organic cationic species. The adverse effect on 
sensitivity observed for the lidocaine electrode, (induced by the presence of 1 x 10"2 
mol dm"3 histidine and 1 x 10"3 mol dm"3 nicotinamide), and the bupivacaine selective 
electrode (with 1 x 10"2 mol dm"3 vitamin Bi) will probably be reduced significantly at 
the much lower levels of these interferents in serum. 
The study showed the TECOFLEX based electroactive membranes to be preferable to 
PVC based membranes for measurements in protein containing solutions. The drift 
induced by the protein on baseline potentials and peak height reproducibility in the FIA 
experiments was substantially smaller with TECOFLEX rather than PVC as the 
membrane matrix. 
Flow injection analysis is a particularly suitable technique for the rapid analysis of 
samples of small volume. The combination with ion-selective electrodes has previously 
been shown to confer the advantages of increased sensitivity, decreased chemical 
interference, fast response time and good reproducibility of results'381 to an analysis 
system. The experimental results show that the determination of lidocaine in protein 
containing samples can be achieved by the combination of FIA, with a TECOFLEX 
based ion-selective polymer-membrane. This means that a lidocaine analysis in 'real' 
clinical samples could be achieved. 
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Chapter Three 
The Potentiometric and Amperometrk Detection of 
Antidepressants 
3.1 Introduction 
The chapter contains an introduction to some of the properties of tricyclic 
antidepressants (section 3.1.1). The analytical methods which have been applied to the 
detection of antidepressants are discussed (section 3.1.2). The experimental studies 
performed are described in section 3.2. The results from the potentiometric and 
amperometric experiments are presented and discussed in section 3.3. 
3.1.1 Antidepressants 
The tricylic antidepressants imipramine, desipramine and trimipramine are some of the 
most important antidepressant drugs in current clinical use. The first of them, 
imipramine was discovered by Kuhn in the 1950's. 
The tricyclic antidepressants are all lipophilic and relatively strong bases, as shown by 
their high pK a values (imipramine 9.4, desipramine 10.2, trimipramine is the exception 
7.72). As with many basic drugs, this class of compound bind to plasma proteins, in 
particular ai-acid glycoprotein (AAG). This can lead to problems as the levels of this 
protein can vary depending on the condition of the patient, for example, inflammatory 
disease which increases the levels of A A G [ 1 l 
Their primary mode of action as antidepressants is believed to be inhibition of the 
uptake of catecholamines (specifically noradrenaline) by the nerve terminals. This may 
occur via competition for the carrier protein that forms part of the membrane transport 
system. 
Their relatively low concentration in physiological fluids (therapeutic concentration ~ 
10"7 to 10"8 mol dm"3) is indicative of their effectiveness. Levels above this range lead 
to adverse effects; seizures, unconsciousness, cardiac arrhythmia and respiratory 
depression'2'. Their low concentration and the large number of metabolites formed by 
the tricyclic antidepressants means that any detection method should be both sensitive 
and selective. Bearing this in mind, the current preferred detection method for most 
tricyclic antidepressants is HPLC [ 1 ' 3 1. 
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3.1.2 Detection of Antidepressants 
Various rather tedious methods for the measurement of tricyclic antidepressants are 
currently used'4'. A common theme amongst the majority of these is the need for the 
drugs to be extracted from the biological matrix before analysis. The methods used 
have included spectrophotometric techniques, gas-liquid chromatography (GLC), high-
performance liquid chromatography (HPLC) and radioimmunoassay (RIA). Some 
electrochemical methods have also been described since they have the ability to 
determine analyte concentrations directly in whole blood, serum or urine without any 
extraction steps. 
3.1.2.1 Spectrophotometric Techniques 
Spectrophotometric techniques were among the first methods used to detect these 
molecules. However, the specificity of the methods described was poor, with the 
metabolites of the parent drug causing a significant level of interference. However, a 
recent flow injection chemiluminescence detection method described by Townshead'5' 
showed both excellent detection limits for imipramine (5 x 10" mol dm ) and low 
interference was observed from constituents of human urine (e.g. uric acid). 
3.1.2.2 Gas-liquid Chromatography 
Gas chromatography is the most widely used method for detection of tricyclic 
antidepressants, indeed GC-coupled with nitrogen detection'6' is the preferred method of 
analysis for imipramine, desipramine and trimipramine hydrochlorides. Limits of 
detection are of 5, 1 and 0.5 ug/1 (1.6 x 10"8, 3.3 x 10"9 and 1.5 x 10"9 mol dm"3) for 
imipramine, desipramine and trimipramine respectively. I f mass spectrometric analysis 
is used instead of nitrogen detection, the detection limits can be improved by three 
orders of magnitude'7'. However, the methods do require the time consuming extraction 
of the analyte from the plasma phase into a volatile solvent. The advantage of this 
technique over spectrophotometry is its ability to separate the metabolites from the 
parent drug because of their difference retention times on a capillary column. 
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Therefore, not only the parent drug but also the metabolites are detected, some of which 
also have antidepressant activity. 
3.1.2.3 High-performance Liquid Chromatography (HPLC) 
This method has also been applied to the detection of most tricyclic antidepressants. 
The preferred methodology involves use of a reverse phase, column to improve the 
column efficiency, coupled to a UV or amperometric detector. When using an 
amperometric detector detection limits of 1.6 x 10" and 1.7 x 10" mol dm" have been 
reported for imipramine and desipramine respectively'8'. However, extraction of the 
analyte from the plasma matrix is still required'9'. 
3.1.2.4 Radioimmunoassay 
Radioimmunoassay techniques have the advantages of high sensitivity and rapid 
analysis for small volumes of plasma (<0.5 ml), without the need for extraction of the 
analyte from the plasma'10'. A major problem is the lack of availability of tritium-
labelled tracers with high specific activity, and the inherent cost of these radiolabelled 
molecules. 
3.1.2.5 Electrochemical Analysis 
As mentioned above (section 3.1.1), the use of ISEs to monitor levels of clinically 
relevant analytes has several advantages over chromatographic methods. ISEs can 
monitor the concentrations of the required drug continuously, i f necessary. In addition 
the concentration in whole blood can be measured, removing the requirement to 
separate the analyte from the blood matrix. 
Both potentiometric and amperometric methods of detection have been described. 
Potentiometric ion-exchange membrane electrodes have been devised by Cosofret'"' 
and Hopkala'12'. These ISEs however showed slightly sub-Nernstian gradients with 
detection limits of 5 x 10"6 and 6 x 10'5 mol dm"3 respectively. In both cases, the 
electrodes gave modest selectivities over organic and inorganic cationic species such as 
Vitamins Bi and B 6 , ephedrine, K + , Ca 2 + and Mg 2 + . 
81 
Amperometric detection of pharmaceuticals has been used widely and several methods 
have been proposed for the detection of tricyclic compounds'131 since they are easily 
oxidised via a two step, three electron ECE process'14'. An amperometric detection 
scheme was reported by Wang 1 1 5 1, in which differential pulse voltammetry was used, 
following interfacial accumulation at either glassy carbon or carbon paste electrodes. 
With a four minute preconcentration time, detection limits of 1.5 x 10" mol dm" 
8 3 8 3 
imipramine, 1.7 x 10" mol dm" desipramine and 1.4 x 10" mol dm" trimipramine were 
achieved. Biryol et a/.'151 used poly(/V-vinylimidazole)-modified carbon paste 
electrodes to determine imipramine (and amitriptyline) hydrochlorides. They met with 
5 3 
only moderate success, achieving detection limits of approximately 10" mol dm" for 
both analytes. Khodari reported a sensor for trimipramine'171 using a lipid-modified 
carbon paste electrode. The hydrophobic nature of the electrode surface enhances the 
preconcentration of trimipramine with respect to an unmodified electrode. The resulting 
sensor showed a detection limit of 1 x 10"9 mol dm"3 trimipramine with no interference 
from uric acid (known to interact with carbon electrode surfaces). 
82 
3.2 Experimental 
3.2.1 Imipramine Hydrochloride 
3.2.1.1 Potent iom err ic Experimental 
3.2.1.1.1 Calibration. 
The membranes used were; 
1) 2,6 Didodecyl-a-cyclodextrin (1.2 % ) , PVC (32.8 % ) , oNPOE (65.6 % ) , 
TKB (0.4 % ) . 
2) 2,6 Didodecyl-p-cyclodextrin (1.2 % ) , PVC (32.8 % ) , oNPOE (65.6 % ) , 
TKB (0.4 % ) . 
3) 2,3,6 Trioctyl-y-cyclodextrin (1.2 % ) , PVC (32.8 % ) , oNPOE (65.6 % ) , 
TKB (0.4 % ) . 
4) 2,6 Didodecyl-y-cyclodextrin (1.2 % ) , PVC (32.8 % ) , oNPOE (65.6 % ) , 
TKB (0.4 % ) . 
Al l the calibration experiments were carried out using the CVD method described in 
section 5.1.2. The electrodes were conditioned in 1 x 10"3 mol dm"3 imipramine 
hydrochloride for 12 h prior to use. The initial analyte solution used in the CVD was 
1 x 10"1 mol dm"3 imipramine hydrochloride. 
Imipramine hydrochloride was supplied by Sigma (Poole, Dorset, UK). 
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3.2.1.1.2 Effect of interferents on Electrode response 
All measurements were performed using the constant volume dilution method (as 
described in section 5.1.2), the selectivity coefficients were determined using the mixed 
solution method (section 5.1.3). 
The membranes were of the same composition as used in the calibration experiments. 
The interferents used were glycine, nicotinamide hydrochloride, L-histidine and 
'clinical background' cations. The initial solution used consisted of 1 x 10"1 mol dm"3 
imipramine hydrochloride in the presence of the required interferent. The concentration 
of the interferents was; 
1) 'Clinical background' cations 
2) 1 x 10"2 mol dm"3 Glycine with 'clinical background' cations 
3) 1 x 10~2 mol dm"3 Nicotinamide with 'clinical background' cations 
4) 1 x 10"2 mol dm"3 L-Histidine with "clinical background' cations 
The 'clinical background' consisted of 1.45 x 10"1 mol dm"3 NaCl, 4.3 x 10"3 KC1 and 
1.26 x 10"3CaCl2. 
Al l solutions were prepared using de-ionised water. 
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3.2.1.2 Amperometry Experimental 
3.2.1.2.1 Effect of Conditioning Potential 
The working electrode of a screen printed electrode was coated with 1 ul aliquot of a 
solution comprising of 5 % 2,6 didodecyl-a-cyclodextrin, 40 % TECOFLEX SG80, 
55.4 % oNPOE, 0.6 % TKB in THF. Before use, the solvent was allowed to evaporate 
slowly, and the electrode was soaked for 1 h in an analyte solution prior to beginning 
any experiments. 
The analyte solutions studied were of two concentrations 1 x 10"3 and 1 x 10"4 mol dm"3 
imipramine hydrochloride in 0.05 mol dm"3, pH 7 phosphate buffer. 
The voltammograms were recorded using the square wave voltammetry technique. The 
initial conditions used were, 
Conditioning Potential: -
Equilibrium Time: 80 s 
Frequency: 5 Hz 
Scan Increment: 2 mV 
Pulse Amplitude: 2.5 x 10"2 V 
Voltage Range: 0 to +0.75 V 
Subsequently, the method of detection was optimised by introducing conditioning 
potentials of+0.57 V for 20s followed by -0.2 V for 30s. 
3.2.1.2.2 Calibration using Square Wave Voltammetry 
A screen printed electrode was coated as described in the previous section. The 
equipment was configured as described in section 5.2.1). The modified electrode used 
was soaked for 1 h in analyte solution prior to use. The square wave voltammograms 
were recorded using the optimised conditions described previously. 
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The imipramine hydrochloride solutions used were prepared by serial dilution from 
1 x 10"3 to 1 x 1(T9 mol dm"3 in a background of 0.05 mol dm"3, pH 7 phosphate buffer. 
The experimental conditions detailed above were subsequently used in the investigation 
of desipramine and trimipramine. 
3.2.1.2.3 Exhaustive Electrolysis 
Exhaustive electrolysis was performed only on an imipramine solution to give 
information on the nature of the analyte oxidation. This was performed using the MF-
1056 electrolysis cell described later (section 5.2.2). The technique used was controlled 
potential coulometry, the conditions used were; 
Initial Potential: +0.57 V 
Time: 16 h 
After the electrolysis, a square wave voltammogram was recorded using the conditions 
described in the previous section. The solution utilised was 1 xlO"4 mol dm"3 
imipramine hydrochloride in phosphate buffer. 
3.2.1.2.4 Effect of cyclodextrin on response 
The effect of the alkylated a-, P- and y-cyclodextrins on the electrode response was 
studied using desipramine. Glassy carbon electrodes were modified in two ways: 
Approximately 1 jul of 1 x 10"2 mol dm' 3 cyclodextrin in acetonitrile was deposited on a 
clean glassy carbon surface and the solvent allowed to evaporate. The cyclodextrins 
used were the didodecyl substituted a-, (3- and y-cyclodextrins. 
A Membrane comprising of 5 % cyclodextrin, 40 % TECOFLEX SG 80, 55.4 % 
oNPOE and 0.6 % TKB in THF was deposited on a clean glassy carbon electrode 
surface and the THF allowed to evaporate. The cyclodextrin used was either 2,6 
didodecyl-a-cyclodextrin or 2,6 didodecyl-y-cyclodextrin. 
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The cyclic voltammograms were produced using the experimental configuration 
described in section 5.2.1. The conditions used were, scan rate 200 mV/s, scan 
increment 2mV, voltage range +0.2 to +1.0 V. 
Before each experiment the electrode was allowed to soak for 1 h prior to the beginning 
of a run. 
The analyte solution was 1 x 10"3 mol dm"3 desipramine hydrochloride in 0.05 mol dm"3, 
pH 7 phosphate buffer. The phosphate buffer was supplied by BDH (Poole, Dorset). 
3.2.1.2.5 pH Dependence 
A screen printed electrode was modified as described in the previous section. 
The pH of a 1 x 10"4 mol dm"3 trimipramine hydrochloride solution in phosphate buffer 
was adjusted over the pH range 6 to 9. 
Over this range, the electrode response was studied using the square wave voltammetry 
method with the optimised conditions described in section 3.2.1.2.1. 
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3.3 Results and Discussion 
The detection of imipramine, desipramine and trimipramine hydrochlorides were 
studied by both potentiometnc and voltammetrie methods. 
3.3.1 Potentiometric Methods of Analysis 
The potentiometric analysis used Philips body electrodes incorporating a polymer 
membranes described previously in section 3.2. 
3.3.1.1 Calibration Results and Discussion 
Calibration experiments using the constant volume dilution method were performed for 
all the antidepressants. The electrodes incorporating the alkylated cyclodextrins 
responded well to the presence of imipramine hydrochloride (see figure 3.3.1.1 and 
table 3.3.1.1), with Nernstian responses and good limits of detection (~ 10"5 mol dm"3). 
A comparison of the responses from electrodes incorporating the di- and tri-alkylated y-
cyclodextrins revealed little or no difference in response due to the change in alkylation 
pattern. This behaviour has been observed previously for guanidine and other achiral 
guest molecules'181 in which the presence of the free hydroxyl had little effect on the 
binding of the guests. Such behaviour implies that these molecules are not involved in a 
hydrogen-bonding interaction with the 3-position. Instead the binding to the 
cyclodextrin may involve N-H donation to the 2,6-ring oxygens. 
The calibration data for all the electrodes compare favourably with those obtained by 
the Cosofret'111 and Hopkala [ 1 2 i groups. The results obtained by incorporating 
cyclodextrins into the electrodes gave better slopes than those reported previously by 
other groups' 1 1 1 2 ' (gradients 53.3 and 51.0 mV/decade respectively for Cosofret et al. 
and Hopkala et al.) where the sensing was based on ion-pair association between 
imipramine and a lipophilic anion (e.g. dinonylnaphthalenesulphonate). The limits of 
detection obtained were comparable to those obtained by Hopkala (~ 10"5 mol dm"3), 
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but, they were a decade lower than those reported by Cosofret with the imipramine-
dinonylnaphthlane sulphonic acid ion-pair f l l ]. 
350 2,6 Didodecvl-a-cvclodextrin, PVC, oNPOE, T K B 
2,6 Didodecyl-R-cyclodextrin, PVC, oNPOE, T K B 
2,6 Didodecyl-Y-cyclodextrin, PVC, oNPOE, T K B 
300 2,3,6 Trioctyl-Y-cyclodextrin, PVC, oNPOE, T K B 
Theoretical Nernstian Gradient 
250 
3, 200 
150 
100 
50 
1 
Log [Imipramine] 
Figure 3.3.1.1. Electrode response curves for imipramine sensitive electrodes. 
Ionophore Gradient (mV/decade) Limit of Detection 
(mol dm"3) 
2,6Ci2aCD 54.5 2.6 x 10"5 
2,6Ci2(3CD 59.9 6.4 x 10"5 
2,6C 1 2 YCD 54.2 1.0 x 10"5 
2,3,6C8yCD 56.1 5.0 x 10"5 
Table 3.3.1.1 Imipramine Calibration Results at 298 K. 
Electrodes incorporating alkylated cyclodextrins all produced excellent calibration 
results for the determination of desipramine hydrochloride, and gave good Nernstian 
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gradients and excellent limits of detection (~ 10"5 mol dm"3). The results for the 
calibration are shown in figure 3.3.1.2. and table 3.3.1.2. 
2,6 Didodecyl-a-cyclodextrin, PVC, oNPOE, T K B 
2,6 Didodecvl-P-cyclodextrin, PVC, oNPOE, T K B 
250 2,6 Didodecyl-y-cyclodextnn, PVC, oNPOE, T K B 
Theoretical Nernstian Gradient 
200 
3 150 
« 100 
50 
j i i 
Log [Desipramme] 
Figure 3.3.1.2. Desipramine Calibration results. 
lonophore Gradient (mV/decade) Limit of Detection 
(mol dm"3) 
2,6Ci 2aCD 60.0 9.9 x 10"6 
2 ,6C 1 2pCD 54.5 1.6 xlO" 5 
2,6Ci2YCD 59.6 9.5 x 10"6 
Table 3.3.1.2. Desipramine Calibration Results at 298 K. 
The calibration experiments performed using electrodes incorporating 2,6 didodecyl-a-, 
P- and y-cyclodextrins as the ionophore for the detection of trimipramine hydrochloride 
produced the results shown in figure 3.3.1.3. and table 3.3.1.3. The results revealed 
excellent limits of detection and Nernstian gradients for both the a- and y-cyclodextrins, 
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with a slightly sub-Nernstian gradient for the electrode incorporating 2,6 didodecyl-(3-
cyclodextrin. 
2,6 Didodecyl-a-cyclodextrin, PVC, oNPOE, T K B 250 
2,6 Didodecvl-P-cyclodextnn, PVC, oNPOE, T K B 
2,6 Didodecvl-y-cyclodextnn, PVC, oNPOE, T K B 
Theoretical Nernstian Gradient 
200 
150 > 
100 
4> 
50 
0 
4 
•Log [Trimipramine] 
Figure 3.3.1.3. Electrode response curves for trimipramine sensitive electrodes. 
lonophore Gradient (mV/decade) Limit of Detection 
(mol dm"3) 
2,6Ci2aCD 60.3 2.7 x 10" 
2,6C12PCD 47.5 4.2 x 10"
5 
2 , 6 C 1 2 Y C D 57.0 1.4 x 10"5 
Table 3.3.1.3 Calibration Results for trimipramine sensitive electrode incorporating 
various alkylated cyclodextrin ionophores at 298 K. 
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3.3.1.2 Interference Studies 
The interference from a variety of species found in serum on the electrode response 
characteristics of imipramine, desipramine and trimipramine hydrochloride sensitive 
electrodes was studied. The simulated 'clinical background' contained 1.45 x 10"1 mol 
dm"3 NaCl, 4.3 x 10"3 mol dm"3 KC1 and 1.26 x 10"3 mol dm"3 CaCl2 which correspond 
to values within the normal physiological range observed for these ions. The 
concentration of all other interferents (glycine, histidine and nicotinamide) was 
arbitrarily set at 1 x 10"2 mol dm"3. It must be noted however that the normal 
physiological range of these molecules is almost 100 times lower, glycine (1.46 x 10"4 -
3.52 x 10"4 mol dm"3), histidine (7.3 x 10"5 - 1.25 x 10"4 mol dm' 3), and nicotinamide 
(3.3 x 10"5 - 7.4 x 10"5 mol dm"3). 
The results of the electrode response from the interference studies for imipramine 
hydrochloride are shown in table 3.3.1.2.1. In the presence of serum levels of Na +, K + 
and Ca 2 + the limit of detection was unaffected. Also Nernstian response was maintained 
and excellent selectivity coefficients (-log Ky°', overall > 3.6) were observed. This is 
consistent with the known characteristics of cyclodextrin inclusion complexes'191. The 
hydrophobic nature of the cyclodextrin cavity precludes the inclusion of the charge 
dense cations such as those present in the serum background. The cyclodextrin prefers 
to include the hydrophobic, charge diffuse head group of the tricyclic molecule. 
The interference from various likely interfering species on the electrode response was 
studied for the imipramine electrodes incorporating the alkylated cyclodextrins (table 
3.3.1.2.1). With an interferent concentration of 1 x 10 2 mol dm"3 in the presence of the 
serum background, no interference was noted for glycine. However, the presence of 
both nicotinamide and L-histidine resulted in reduced gradients and poor selectivity 
when 2,6 didodecyl-ot-cyclodextrin was the ionophore. The results have not been 
reported in terms of selectivity coefficients for nicotinamide since it was primarily non-
ionic at the experimental pH (~ 6) and in the physiological pH (-7.4). The interference 
may be related to competitive inclusion in the cyclodextrin cavity. However, since the 
interferent is not fully ionised it can not compete with imipramine for charge induced 
membrane transport. 
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The results from desipramine electrode studies with both organic and inorganic cationic 
interferent molecules are shown in table 3.3.1.2.2. In the presence of serum levels of 
Na +, K + and Ca 2 +, the electrode response remained excellent. The limit of detection was 
unaffected, as was the Nernstian gradient. The selectivity coefficient for each of the 
electrodes studied was also good (-log K^°', overall > 3.6). When the organic 
interferents were present (glycine, nicotinamide and L-histidine) along with the serum 
levels of Na +, K + and Ca 2 +, the response of the electrodes was, on the whole, unaffected. 
For both glycine and L-histidine, their presence had effect on either the limit of 
detection or the gradient. With nicotinamide, the electrodes incorporating 2,6 
didodecyl-a- and y-cyclodextrin showed no interference. However, the electrode 
incorporating 2,6 didodecyl-P-cyclodextrin showed a significant reduction in the 
gradient. This may be due to competitive binding between the nicotinamide and 
desipramine analyte for the cyclodextrin cavity. 
The effect of interferents on the trimipramine sensitive electrode are tabulated in table 
3.3.1.2.3. The effect of the serum background on the electrode response was minimal, 
with excellent selectivity coefficients being recorded (-log Ky0t, overall > 3.7). In the 
presence of 1 xlO"2 mol dm"3 glycine and nicotinamide (both with a background of 
serum cations), the response of the electrodes were unaffected with Nernstian gradients 
and limits of detection being maintained. However, studying the effect of L-histidine 
on the trimipramine electrode response was not possible due to the formation of a white 
precipitate. 
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3.3.1.3 Summary 
From the results obtained for imipramine, desipramine and trimipramine hydrochlorides 
some general conclusions may be drawn. 
The initial electrode potentials (E° M , ) from the aqueous calibrations for imipramine and 
desipramine hydrochloride were in the order: 2,6Ci2a>2,6CnP>2,6Ci2Y=2,3,6C8Y 
whereas for trimipramine the (E° I n j t ) order was: 2,6Ci2Y>2,6Ci2a>2,6Ci2|3. 
Such trends suggest that the Gibbs free energy of binding (AG=-nFE) associated with 
the inclusion of the hydrophobic side chains of imipramine and desipramine 
hydrochloride in the a- and P-cyclodextrin cavities is more favourable than that of the 
bulkier side chain of trimipramine hydrochloride. The bulkier trimethylated side chain 
of trimipramine appears be more strongly bound by the larger y-cyclodextrin cavity. An 
alternative hypothesis could be that due to the increased size of the y-cyclodextrin 
cavity, the tricyclic moiety itself may be included rather than the less bulky side chain. 
The results presented constitute the first detection method using neutral ionophores for 
any of these tricyclic antidepressants. The electrode response is sufficient to determine 
the levels of these drugs in pharmaceutical preparations (e.g. for drug quality control). 
However the limits of detection are not sufficiently low to allow the assay of the drugs 
in plasma samples, unless the dependence of potential on -log [analyte] in the non-linear 
region of the calibration graph can be determined. This method has been reported 
previously by Kereichuk'20' and used in the detection of lidocaine. 
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3.3.2 Amperometric Detection 
Amperometric detection has the inherent advantage of a superior detection limit with 
respect to potentiometric detection (~ 10"10 moi dm"3 compared to ~ 10"6 mo'i dm 3 ) . 
Also, the tricyclic electron rich aryl moiety of these molecules appears ideal for 
oxidation. Indeed previous work by Bard, Faulkner and Ledwith [ H 1 reported a two step, 
three electron ECE mechanism for the oxidation of these molecules. 
3.3.2.1 pH Dependence 
The pH of a solution containing 1 xlO"* mol dm"3 trimipramine hydrochloride in 
phosphate buffer was adjusted over the pH range 6-9, and the peak current was recorded 
for the peak at +0.18 V. The results of these studies are shown in figure 3.3.2.1.1. 
It can be seen that the response of the electrode rapidly decreases both above and below 
pH 7. The reduced response in acidic media is consistent with the mechanism proposed 
by Ambrose et alJn\ They showed that the oxidation of similar tricyclic compounds 
was via an ECE (electrochemical-chemical-electrochemical) mechanism (figure 
3.3.2.1.2). 
O, +nje <-> R-! 
2R,— k ->0 2 
02 + n 2 e < - » R 2 
Figure 3.3.2.1.2 ECE Mechanism. 
We can clearly see in the scheme (scheme 3.3.2.4) that the rate of the chemical coupling 
step would be reduced as the acidity of the analyte solution increased, due to the 
involvement of protons in that step. 
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Figure 3.3.2.1.1. Peak Current Density dependence on pH for a 1 x 10"4 mol dm"3 
trimipramine hydrochloride solution. 
3.3.2.2 Variation of the Conditioning Potential 
The optimum conditions for accumulation of the tricyclic antidepressants were initially 
determined using a desipramine hydrochloride solution (1 x 10"4 mol dm"3) in a 
phosphate buffer (0.05 mol dm"3, pH 7). 
Using a bare screen-printed electrode (SPE), the square wave voltammogram (SQW) 
gave an initial oxidation peak at +0.57 V (vs. Ag/AgCl). This peak tended to decrease 
in intensity as successive runs were performed while the intensity of a second peak at 
+0.18 V grew (figure 3.3.2.2.1.). 
When an SPE that was coated with the membrane material was used, the second peak at 
+0.18 V was more significant. On successive runs the height of the peak at +0.18 V 
increased. This suggested that as the first species was oxidised more of the second 
species was produced with a lower redox potential. 
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The signal at +0.18 V was further enhanced by applying a negative potential of -0.2 V 
to the electrode, after the +0.57 V (generating the monomer cation radical). This means 
that the optimum experimental conditions used for accumulation were 20s at +0.57 V 
followed by 30 s at -0.2V The applied negative potential probably preconcentrates the 
cation radical, thereby reducing the decrease in peak current due to diffusion of this 
intermediate species. 
Figure 3.3.2.2.2 shows the effect of repeated experiments using a 1 x 10"5 mol dm"3 
trimipramine hydrochloride solution in phosphate buffer. As can clearly be seen the 
peak current density (from peak at +0.18 V) rapidly increases over the first hour of 
accumulation time. After this, the current density begins to decline. Such a decrease in 
current density was also noted by Wang et al. who believed that it was due to the 
formation of an inhibiting film. This hypothesis may be correct, since the ECE process 
could potentially form oligomers of greater size than a dimer. This could be facilitated 
by the monomer cation radical reacting with a cation monomer rather than another 
radical unit, leading to a radical dimer unit which could then continue reacting. These 
larger oligomers could potentially be a source of this inhibiting fi lm, which reduces the 
current density, by physically blocking the cyclodextrin binding sites. 
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Bare Electrode 
coated electrode first scan 
coated elctrode second scan 
coated electrode third scan 
conditioned: coated electrode 
0.22 -
0.20 -
8 0.12 
0.2 0.4 0.6 
E vs. AgCl (V) 
Figure 3.3.2.2.1. Effect of applying a conditioning potential to a 1 x 10 mol 
desipramine hydrochloride solution. 
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Figure 3.3.2.2.2. Variation of peak current at +0.18 V (vs. AgCl) with Conditioning 
Potential. 
3.3.2.3 Concentration Dependence 
Using the optimum conditions described in the previous section the peak current density 
at +0.18 V (after conditioning) was recorded for desipramine, imipramine and 
trimipramine hydrochlorides over the concentration range between 1 x 10"9 and 1 x 10"4 
mol dm"3 (figure 3.3.2.3a). Shown in figure 3.3.2.3b is the electrode response from a 
solution containing 1 x 10"9 to 1 x 10"4 mol dm"3 of imipramine hydrochloride. 
With solutions more concentrated than 1 x 10"4 mol dm"3, the peak at +0.18 V decreased 
whilst the peak at +0.57 V increased (figure 3.3.2.3c). The decrease in the +0.18 V 
peak is probably due to the greater production of higher molecular weight oligomers at 
this higher concentration; the observed shoulder may be tentatively ascribed to the 
production of a trimer. The position of this oxidative wave is the same as that observed 
in the exhaustive electrolysis of a solution containing 1 x 10"4 mol dm"3 imipramine 
(section 3.3.2.4). 
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Figure 3.3.2.3a. Concentration dependence versus peak height for imipramine, 
desipramine and trimipramine hydrochloride in phosphate buffer. 
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Figure 3.3.2.3b. Electrode response to varying concentration of imipramine 
hydrochloride in phosphate buffer (0.05 mol dm"3, pH 7). A: background, B: 1 x 10"9 
mol dm"3, C: 1 x 10"8 mol dm"3, D: 1 x 10"7 mol dm"3, E: 1 x 10"6 mol dm"3, F: 1 x 10"5 
mol dm"3, G: 1 x 10"4 mol dm"3. 
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Figure 3.3.2.3c. Response trace for 1 x 10"3 mol dm"3 imipramine in phosphate buffer. 
3.3.2.4 Mechanism of Detection 
3.3.2.4.1 Mechanistic Analysis using Glassy Carbon Electrodes 
A square wave voltammogram of a solution containing 1 x 10"4 mol dm"3 imipramine 
hydrochloride in phosphate buffer (0.05 mol dm"3, pH 7) was run using a glass carbon 
electrode. Data were analysed using Model 271 Cool Kinetic Analysis Software. This 
data analysis showed the oxidation to be consistent with a two step ECE mechanism 
(scheme 3.3.2.4). The mechanistic scheme is initiated by a one electron oxidation at 
nitrogen with formation of a radical cation (rate limiting step). This radical ion can 
exist in several resonance forms. The radical cation then dimerises, and the 
dimerisation is accompanied by the loss of two protons per dimer (hence the pH 
dependence). The dimer, being more easily oxidised than the monomer, is oxidised at a 
lower potential (72 mV vs. Ag/AgCl) to produce the dication, with the loss of two 
electrons per dimer. 
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Figure 3.3.2.4.1.1 shows the current response obtained when performing square wave 
voltammetry experiments on both a fresh 1 x 10"4 mol dm"3 imipramine solution and one 
which had been exhaustively electrolysed at +0.57 V (vs. Ag/AgCl). The peak at 809 
mV is associated with the formation of the radical cation, which then undergoes a 
coupling reaction to form the dimer. The dimer is then oxidised at the lower potential 
of 72 mV to form the stable cation. Present in the voltammogram of the electrolysed 
solution was another peak at 315 mV. This may be due to the oxidation of trimer 
molecules, formed from the dimer via a coupling reaction with another radical cation. 
The results obtained using the alkylated cyclodextrin modified electrodes were also 
analysed. The results from three voltammograms obtained using (shown in figure 
3.3.2.4.1.2); 
1. A bare screen-printed electrode, 
2. A modified electrode without conditioning at +0.57 V (vs. Ag/AgCl), 
3. A modified electrode with conditioning at +0.57 V (vs. Ag/AgCl). 
The greatly increased peak current density and enhanced sensitivity upon modification 
of the electrode was evident. The voltammogram without conditioning exhibited only a 
single peak at 550 mV (vs. Ag/AgCl). Again, this peak is consistent with a one-electron 
oxidation process involving the formation of a radical cation species by removal of an 
electron from the ring nitrogen. 
However, upon applying the conditioning potential, a second peak at 178 mV (vs. 
Ag/AgCl) appears. The analysis of this peak shows it to be due to a two-electron 
oxidation, the dimer species formed after the coupling reaction is being oxidised to a 
cationic species. In contrast to the exhaustively electrolysed solution, there appears to 
be no separate third peak at 316 mV. However, the shoulder of the dimer oxidation 
peak is at the correct potential and does consistently increase in height, until at the 
highest concentration studied it does appear as an indication of a peak. As there wil l 
always be some trimer formed, the shoulder is always present in the voltammograms, 
although it appears only at the highest concentration. 
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Scheme 3.3.2.4 Mechanism of imipramine oxidation. 
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Figure 3.3.2.4.1.1. Square wave voltammogram of a 1 x 10"4 mol dm"3 imipramine 
solution in phosphate buffer, before and after exhaustive electrolysis. 
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Figure 3.3.2.4.1.2. Comparison of voltammograms for a 1 x 10"4 mol dm"3 imipramine 
hydrochloride solution in pH 7 phosphate buffer. 
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3.3.2.5 Effect of the Background Electrolyte 
The effect of varying the background electrolyte was studied in order to gain further 
insight into the mechanism Square wave voltammograms of 1 x 10"4 mol dm"3 
imipramine hydrochloride were recorded in 0.1 mol dm"3 NaCl (pH 6.5), 0.1 mol dm"3 
NaC104 (pH 7.15), acetate buffer (pH 4.5), cacodylate buffer (pH 7.2) and phosphate 
buffer (pH 7.0) using the optimum conditions described earlier (section 3.2.1.2.1). 
Oxidation peaks were not observed in the presence of acetate, perchlorate or cacodylate. 
In a background of 0.1 mol dm"3 NaCl, two peaks were observed at 747 mV and 1107 
mV (vs. Ag/AgCl), whose intensity varied with concentration down to 1 x 10° mol dm"3 
imipramine hydrochloride. When a background of 1 x 10"3 mol dm"3 NaCl with 
increasing levels of KH2PO4 was used, a peak was observed at 100 mV (figure 
3.3.2.5.1). The response in the presence of phosphate showed the peaks discussed 
earlier (section 3.3.2.3). 
These results may be correlated with the variation in the lipophilicities of the anions 
used. Lipophilic anions are known to form relatively strong inclusion complexes with 
cyclodextrins via hydrophobic and/or hydrogen bonding, with larger binding constants 
than non-lipophilic anions (e.g. 33 dm 3 mol"1 for C104" [ 2 2 1 and 1.6 dm 3 mol"1 for Cl" l 2 3 ]). 
This relatively strong binding may block the cyclodextrin cavity and consequently 
prevent substrate inclusion thereby prohibiting the transport of the substrate to the 
electrode surface. As a consequence no redox peaks are observed. The less lipophilic 
anions chloride and phosphate have been shown by NMR studies to be included, only to 
a very small extent into a-cyclodextrin cavities [23]. Since these anions are associated 
with the periphery of the cyclodextrin, it is plausible that they may stabilise the radical 
cation once it has been formed by ion-pairing interactions. The phosphate ions are the 
only anions capable of facilitating the detection of very low levels of analyte. The 
phosphate anions, H 2P0 4" and HP0 4 2" can act as both hydrogen bond donors and 
acceptors. It seems likely that the alkylated cyclodextrin on the membrane surface has 
associated with it a phosphate anion that can form an ion pair with the imipramine 
through electrostatic and direct hydrogen bonding. The phosphate anion may then also 
stabilise the intermediate radical cation once it is formed. 
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Though the use of a chloride background also led to the detection of imipramine, the 
response was severely reduced (a detection limit of 1 x 10"5 compared to 1 x 10"9 mol 
dm"3 with HP0 4 2"). 
The signal amplification observed with the modified electrodes may be due to a 
co-operative response. The encapsulating membrane can be considered to act as a 
lipophilic matrix within which large lipophilic anions (i.e. the tetraphenyl borate salt) 
and alkylated cyclodextrin ionophore are embedded. The cyclodextrin ionophore may 
form inclusion complexes with the anions (of the electrolyte solution) either strongly, 
hence blocking the cavity (lipophilic anions), or may be weakly associated with them, 
facilitating ion exchange. The cationic analyte is then attracted to the membrane surface 
where a small change in the electrolytic environment triggers the co-operative response. 
Such interactions have been widely studied in phospholipids and other biological 
membranes1241, and it is possible that polymer membranes with embedded anionic sites 
may be involved in similar interactions. 
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Figure 3.3.2.5.1. Effect of anions on square wave voltammograms of 1 x 10"4 mol dm 
solutions of imipramine hydrochloride using coated screen-printed electrodes. 
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3.3.2.6 Summary 
The interactions between cyclodextrins and tricyclic antidepressants have been studied 
previously'251. However this was the first instance where modified cyclodextrins had 
been used to aid preconcentration of these analytes. The amperometric sensors reported 
showed subnanomolar levels of detection could be achieved by depositing alkylated 
cyclodextrins in a plasticised polymer matrix on to a screen printed carbon electrode. 
The resulting sensor possessed the detection limit required to facilitate detection of the 
analytes in clinical media. 
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Chapter Four 
A Study of Cyclodextrin Enantioselectivity 
4.1 Introduction 
The work in this chapter reports the studies performed relating to enantioselectivity in 
complexation with cyclodextrins. J he primary analyte of interest was the fi-blocker 
propranolol. This analyte was chosen because clinically the racemate is administered, 
but only the S(-) enantiomer is therapeutically active as a P - b l o c k e r ^ 1 , 2 j T h e r e f o r e a 
means of determining the concentration of the therapeutically active enantiomer is of 
significant interest. Various other clinical analytes of a similar structure have also 
been studied, with the aim of gaining a better understanding of the nature of the 
enantioselectivity shown by cyclodextrins. The chiral centre of the clinical analytes was 
in a position /3 to the aromatic ring system. Another group of compounds has also been 
studied for purposes of comparison, including a series of benzylamine derivatives with 
the chiral centre a to the aromatic ring. The aim was to assess the effect of shifting the 
position of the chiral centre on the enantioselectivity. 
4.1.1 How to distinguish enantiomers? 
It has been well known for many years that it is desirable to separate enantiomers of 
drug compounds because, at best, one enantiomer would be inactive and at worst, it 
would be toxic. A prime example of this is penicillamine where the (S)-enantiomer is 
an antiarthritic drug whereas the (R)-enantiomer is extremely toxic. 
During the last decade, rapid progress has been achieved in the use of chiral stationary 
phases for both GLC and HPLC. This has been due largely to the synthesis of new 
chiral stationary phases which have incorporated modified cyclodextrins. Peralkylated 
cyclodextrins have proved to be among the most successful of the chiral stationary 
phases developed recently, and they have been successfully used in the separation of 
ephedrine enantiomers[3]. Indeed, many molecular modelling studies have been 
performed on such systems in an attempt to understand the mechanism of 
enantioselectivity[4,5]. 
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NMR has also been used to distinguish between enantiomers. Although this technique 
cannot distinguish between enantiomers directly because the resonance of the 
enantiomeric nuclei are isochronous, diastereoisomers may be distinguished because 
certain resonances will be anisochronous'6l This approach requires the use of a chiral 
auxiliary that will convert the mixture of enantiomers into a diastereoisomeric mixture. 
As long as there is a sufficiently large chemical shift non-equivalence to give a baseline 
resolution of the appropriate signals, then integration gives a direct measure of 
diastereoisomeric composition. This can then be directly related to the enantiomeric 
composition of the original mixture. There are three types of chiral auxiliary available 
(figure 4.1.1.1). Lanthanide shift reagents (LSR) and chiral solvating agents (CSA) 
form diastereoisomeric complexes with substrate enantiomers and may be used directly; 
chiral derivatising agents (CDA) require the separate formation of discrete 
diastereoisomers prior to NMR analysis. Care has to be taken to prevent kinetic 
resolution or racemisation of the derivatizing agent during derivatization[?I. 
Cyclodextrins have been used as chiral complexing agents to help resolve enantiomers; 
for example Greatbanks[8] has used P-cyclodextrin to distinguish the enantiomers of 
propranolol with moderate success. 
tBu 
O 
M e « r \ Eu M e ! T \ o HOoC CF H NHR 
Tris(pivaloyl-d-camphorato) (R)-l-phenyl (S)-MTPA 
-Europium (Eu[pvc]3) LSR ethylamine CDA 
CSA 
Figure 4.1.1.1. Examples of Chiral Auxiliaries used in chiral NMR analysis. 
Potentiometric methods of analysis have also been used for chiral discrimination. 
Initially these studies were focused on the discrimination of primary a-aryl ammonium 
ions, such as the ct-phenylethyl ammonium ion. The ionophore used for such work 
needs to be both enantiomerically pure and sufficiently lipophilic to facilitate 
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incorporation in a solvent polymeric membrane. Initial research used derivatized crown 
ether compounds19'10'111, which showed quite good enantiomer selectivity and some 
structural selectivity over competing primary ammonium ions. However, the chiral 
ionophores such as the crown-ether derivatives synthesised by Lehn, showed poor 
selectivity against alkali and alkaline earth metal ions, and were only suitable for chiral 
primary ammonium ions. 
Another technique that has been used to differentiate between enantiomers is 
electrospray mass spectrometry (ESMS). Since ESMS is a 'soft' ionisation technique 
these weakly bound complexes are not broken up in the ionisation process. However, 
this technique does require either that the two enantiomers be run separately and the 
intensities of the signals produced compared1121, or that one of the enantiomers be 
deuterium labelled. This isotopic substitution allows both enantiomers to be injected 
simultaneously and owing to the slight mass difference, the intensities can easily be 
measured'131. 
4.1.2 Longitudinal Relaxation and its application to the study of host-
guest complexes 
Longitudinal magnetisation exists due to the difference between the population of the 
nuclear spin states, a and p\ At thermal equilibrium N a and Np obey the Boltzmann 
distribution law. After this equilibrium is disturbed by the introduction of a radio-
frequency (RF) pulse, the new distributions N a ' and Np' return to their original 
distributions, as a result of longitudinal relaxation which is a first order process. It 
follows that this relaxation involves population changes, so the processes involved are 
those which induce transitions between spin states. The relaxation process may be 
characterised by either a rate constant R], or its reciprocal, a relaxation time, Ti . 
Longitudinal relaxation occurs through five main mechanisms (table 4.1.2.1) and the 
extent to which each of these mechanisms contributes to the relaxation process depends 
upon the species under investigation'141. For the species used as a probe in this work, 
the proton, the dominant sources of relaxation are probably the dipole-dipole and spin-
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rotation relaxation, though no attempt was made to investigate the relative contribution 
of these mechanisms. 
Mechanism Interaction Maximum R (s 1 ) Correlation time (s) 
Quadrupolar Electric 106 te typically 
10 1 2 - lO"1 0 
Spin-Rotation Magnetic 102 ie typically 
10" 1 3- 10"" 
Dipole-dipole Magnetic 1 Te typically 
io l 2 - io - 1 0 
Shielding anisotropy Magnetic IO- 1 Te typically 
1 0 1 2 - 10 1 0 
Scalar coupling Magnetic 10 1 Te typically 
>10^ 
Table 4,1.2.1. Summary of relaxation mechanisms. 
The formation of host guest complexes has a profound effect upon the longitudinal 
relaxation rates of both the host and guest. The association of the molecules leads to 
changes to the reorientation mobility of both the host and guest, resulting in changes to 
t c (rotational correlation time) and hence Ri. The resulting changes in the relaxation 
rate of associated molecules have been used to help gain a clearer picture into their 
complexes. 
Lehn and coworkers' i y | used relaxation rate measurements at various temperatures and 
in various solvents to investigate 'bouquet-shaped' molecules based around a P-
cyclodextrin core. The interest in these highly modified cyclodextrins was as bilayer 
ion channels. The relaxation rate measurements gave information concerning the 
orientation of the functionalised side chains relative to the axis of the cavity. 
Lipkowitz [ 1 6 ] used Ti measurements in conjunction with molecular modelling to 
investigate the binding of tryptophan by oc-cyclodextrin. The work showed some 
modest selectivities, related to the preferential inclusion of the (R)-enantiomer in the 
cyclodextrin cavity. Better enantioselectivity results were shown by this technique 
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when Bates'171 studied the interactions of ephedrine with 'poly'octyl-a-cyclodextrin. 
Significant changes in the relaxation rates of protons associated with the cyclodextrin 
complex of the (+)-enantiomer (R i (F r e e ) = 5.8 s"1, Ri(Bound) = 1.2 s"1 for ephedrine NH (8.2 
ppm) proton) Taken together with other data, this implied that the (+)-ephedrine was 
preferentially included into this modified cyclodextrin. 
4.1.3 Pulsed Gradient Spin-Echo (PGSE) 
Measurement of diffusion coefficients using the PGSE technique'181 has been shown to 
be very useful in gaining information on the degree of association of complexing 
organic host guest systems. Molecular diffusion coefficients are quite sensitive to 
structural changes, binding and association phenomena. This method is particularly 
useful when the host macrocycle has a much larger molecular volume than the guest. 
This situation leads to a large difference in their diffusion coefficients. Upon 
complexation two distinct situations can occur, 
a) slow-exchange between the free and bound component on the NMR timescale, 
which leads to the bound guest possessing a diffusion coefficient that matches that 
of the host. 
b) fast-exchange, wherein the observed diffusion coefficient (D0bS) of the guest will be 
the weighted average of the diffusion coefficients of the free guest (Df r e e ) and that of 
the bound guest ( D c o m ) (equation 1). This allows the calculation of the association 
constant of the complex. 
Doi,s = nxDfree + n2Dcom,«, +n2 = 1 (1) 
In the experiments three distinct diffusion coefficients are measured. The diffusion 
coefficient for both components and for a 1:1 mixed solution. These D values are 
determined by measuring the intensity of a spin-echo in the presence and absence of 
pulsed gradients. The spin-echo is produced by the incomplete refocusing of the signal 
when the molecules diffuse in the presence of an applied field gradient. From the data 
obtained, the diffusion coefficients may be calculated using equation 2; 
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( A \ 
In _ L = - ( m s 2 ) \ A - % ) D (2) 
\ A o J 
where A g and A G are the echo intensities in the presence and in the absence of the pulsed 
gradients respectively, g is the gradient strength (Gem 1), D is the self diffusion 
coefficient of the observed spins ( cmV 1 ) , 5 is the length of the diffusion gradient, A is 
the time separation between the edges of the diffusion gradients and y is the 
gyromagnetic ratio. 
The technique has been applied widely to the investigation of host-guest association 
complexes'19,201. Cohen'211 applied the technique to the study of cyclodextrin 
association complexes and the association constants for y-cyclodextrin (host) with 
various 12-crown-4 compounds (guests) were obtained. 
4.1.4 Propranolol Hydrochloride 
Propranolol was the first P-blocker drug to achieve widespread therapeutic use for 
angina and hypertension. The therapeutic activity of the compound resides solely in the 
S(-) enantiomer, although the R(+) isomer has been shown to have membrane 
stabilising effects. The drug acts as a competitive antagonist at both the Pi and P2 
adrenoceptors (against isoprenaline and adrenaline). In practice it reduces the effect of 
exercise or excitement on heart rate, cardiac output and arterial pressure. Propranolol is 
effective at levels of up to 300 ugf 1 (1 x 10"6 mol dm"3) in plasma; levels above this lead 
to total p blockage and hence cardiac failure. 
The preferred analytical method for determining propranolol involves the use of HPLC 
with a sensitivity of 2 jagl"1 (7 x 10"9 mol dm'3). A variety of stationary phases have 
been used, only some of which have been able to resolve the enantiomers'11. Other 
methods used to monitor drug levels are more indirect as they rely on measuring the 
heart rate and blood pressure'221. 
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The need to resolve, and assess the relative properties of, the enantiomers of this drug is 
acute. At present the racemate is used clinically. The detection method therefore 
requires enantiomer separation to monitor the concentration of the therapeutic 
enantiomer. 
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4.2 Experimental 
The structures of the chiral analytes studies; 
Propranolol Hydrochloride 
TFA 
Methamphetamine Trifluoroacetate 
0,N 
.NH, 
Amphetamine Hydrochloride 
TFA 
Ephedrine Trifluoroacetate 
HC1 
NH 7 
HC1 
Methyl Benzylamine 
Hydrochloride Methyl-4-nitrobenzylamine 
Hydrochloride 
.NH, 
1 -(1 -Naphthyl)ethylamine 
Hydrochloride 
4.2.1 Potentiometric Experimental 
4.2.1.1 Potentiometric Calibration 
All measurements were performed using constant volume dilution (section 5.1.2). 
Calibration experiments were performed with the enantiomers of propranolol, methyl 
benzylamine, l-(l-naphthyl)ethylamine hydrochlorides and methyl-4-mtrobenzylamine. 
The membranes used were; 
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Propranolol:2,6 didodecyl-p-cyclodextrin (1.2 % ) , PVC (32.8 % ) , oNPOE (65.6 %) 
and TKB (0.4 %) 
Amphetamine: 2,6 didodecyl-p-cyclodextrin (1.2 % ) , PVC (32.8 % ) , oNPOE (65.6 %) 
and TKB (0.4 %) 
Methyl benzylamine: 2,6 didodecyl-a-cyclodextrin (1.2 % ) , PVC (32.8 % ) , oNPOE 
(65.6 %) and TKB (0.4 %) 
1-(1-Naphthyl)ethylamine: 2,6 didodecyl-p-cyclodextrin (1.2 % ) , PVC (32.8 % ) , 
oNPOE (65.6 %) and TKB (0.4 %) 
Methy-4-nitrobenzylamine: 2,6 didodecyl-a-cyclodextrin (1.2 % ) , PVC (32.8 % ) , 
BBPA (65.6 %) and TKB (0.4 %) 
For each enantiomer the electroactive membranes were conditioned in 1 x 10" mol dm" 
analyte for 12 h prior to use. 
The initial solution was 1 x 10" mol dm" analyte, and the diluent solution was de-
ionized water. 
R(+) and S(-) propranolol hydrochloride, S(+) and R(-) amphetamine hydrochloride, 
R(+) and S(-) methyl benzylamine hydrochloride, R(+) and S(-) 1-(1-
naphthyl)ethylamine hydrochloride and R(+) and S(-) methyl-4-nitrobenzylamine 
hydrochloride were supplied by Sigma (Poole, Dorset, UK). 
4.2.1.2 Interference Experiments 
Interference studies were performed on the enantiomers of propranolol hydrochloride 
and methyl-4-nitrobenzylamine hydrochloride. 
All measurements were made using the continuous volume dilution (section 5.1.2), the 
selectivity coefficients were determined using the mixed solution method (section 
5.1.3). The membranes used were; 
Propranolol: 2,6 didodecyl-p-cyclodextrin (1.2 % ) , PVC (32.8 % ) , oNPOE (65.6 %) 
and TKB (0.4 %) 
Methyl-4-nitrobenzylamine: 2,6 didodecyl-a-cyclodextrin (1.2 % ) , PVC (32.8 % ) , 
BBPA (65.6 %) and TKB (0.4 %) 
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The interferents used in this work were 'clinical background' cations (1.45 x 10"' mol 
dm' 3 NaCl, 4.3 x 10"3 mol dm' 3 KC1 and 1.26 x 10'3 mol dm"3 CaCl2) for both 
enantiomeric analytes. Sodium chloride, potassium chloride and calcium chloride 
present at a concentration of 1 x 10"2 mol dm"3 were also used as interferents in 
experiments with propranolol. The initial solutions consisted of 1 x 10"2 mol dm"3 
analyte with the required interferent. 
Al l the solutions were prepared using de-ionized water. 
4.2.1.3 Longitudinal Relaxation Rate Measurements 
Longitudinal relaxation rate measurements were performed on the following 
combinations of enantiomeric analytes and cyclodextrin host molecules; 
1. R(+) and S(-) Propranolol with 2,6 didodecyl-p-cyclodextrin 
2. S(+) and R(-) Amphetamine with 2,6 didodecyl-a-cyclodextrin 
3. S(+) and R(-) Amphetamine with 2,6 didodecyl-p-cyclodextrin 
4. (IS, 2R)-(+) and (1R, 2S)-(-) Ephedrine with 2,6 didodecyl-a-cyclodextrin 
5. S(+) and R(-) Methamphetamine with 2,6 didodecyl-a-cyclodextrin 
The solutions were prepared as described previously in section 5.3.1. 
4.2.1.4 Pulse Gradient Spin Echo 
The NMR diffusion experiments were performed as described earlier section 4.1.4. The 
host-guest complexes investigated were; 
1. R(+) and S(-) Propranolol with 2,6 didodecyl-|3-cyclodextrin 
2. S(+) and R(-) Amphetamine with 2,6 didodecyl-P-cyclodextrin 
3. (IS, 2R)-(+) and (1R, 2S)-(-) Ephedrine with 2,6 didodecyl-a-cyclodextrin 
4. (IS, 2R)-(+) and (1R, 2S)-(-) Ephedrine with 2,6 didodecyl-3-methyl-a-
cyclodextrin 
The solutions were prepared and experiments were performed as described in section 
5.3.3. 
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4.3 Electrochemical Response Studies 
4.3.1 Propranolol, Ephedrine and Amphetamine. 
The behaviour of various lipophilic cyclodextrin derivatives as ionophores for the 
enantiomers of these clinically relevant compounds was studied using ion-selective 
electrodes (figure 4.3.1.1.). 
H OH 
R(+) Propranolol 
HO H 
S(-) Propranolol (Np = 1-naphthyl) 
\ / \ " / N H C H 3 
Ph 
(1R.2SM-) Ephedrine 
I NHCH 3 
Ph 
(lS,2R)-(+) Ephedrine 
H ^ j N H 2 
Ph 
R(-) Amphetamine 
H 
Ph 
S(+) Amphetamine 
Figure 4.3.1.1. Clinically relevant chiral analytes studied. 
The electrode responses to both R(+) and S(-) propranolol hydrochloride with 2,6 
didodecyl-P-cyclodextrin as the ionophore were very good. The calibration 
experiments showed a near Nernstian response (57.0 mV/decade) and good limits of 
detection (~10 5 mol dm"3) for both enantiomers. The response was also present in the 
presence of interfering cations. The interferents used were a simulated 'clinical 
background' of sodium (1.45 x 10"1 mol dm"3), potassium (4.3 x 10"3 mol dm"3) and 
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calcium (1.26 x 10"3 mol dm"3) chlorides. Also used were the individual constituents of 
the clinical background at a concentration of 1 x 10"z mol dm"3. These interferents 
caused no effect on the electrode response: in all cases studied Nernstian responses and 
excellent limits of detection were observed (table 4.3.1.1). This behaviour was 
characterised by the excellent selectivity coefficients that were achieved, 
-logic?01, overalls4.0 against clinical background and - l o g ^ 0 ' >3.5 for the individual 
interferents. In each case the initial potential was recorded, and the reading was 
significantly higher for the R(+) enantiomer with respect to the S(-). This showed that 
the ionophore was more sensitive towards the (+) than the (-) enantiomer. For 
propranolol this difference in the measured electrode potential (ca. 30 mV) 
corresponded to a free energy difference of 2.9 kJ mol"1 
=EInitial^ ~ &'initial. O 
AG+/. = -nFAE+/_ (2) 
In addition, a good enantioselectivity K+/.=3.2 was found (K+/. = ER+ - EsiS), where 
ER+ - Es- is the difference in initial potentials for the R(+) and S(-) sensitive electrodes, 
and S is the gradient'91. 
It is likely that the (+)-propranolol interacts more favourably with the cyclodextrin than 
the (-) diastereoisomeric complex. The small free energy difference of 2.9 kJ mol"1 is 
consistent with the energies associated with a single hydrogen-bonding interaction. 
This stabilising interaction could conceivably be present in the (+)-propranolol 
cyclodextrin complex and absent in the diastereoisomeric complex. 
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R(+) Propranolol Hydrochloride 
Initial E (mV) Gradient 
(mV/decade) 
Limit of Detection 
(mol dm"3) 
-log Kjj 
Calibration 251 57.5 2.9 x 10° 
'Clinical' 301 56.1 1.4 x 10"5 4.0 
Na + 258 55.6 9.1 x 10^ 4.0 
293 60.9 1.7 x 10"' 3.8 
C a i + 327 33.1 3.3 x 10"5 3.5 
S(-) Propranolol Hydrochloride 
Initial E (mV) Gradient 
(mV/decade) 
Limit of Detection 
(mol dm"3) 
-log Kjj 
Calibration 239 57.0 1.1 x 10"5 
'Clinical' 270 61.9 7.9 x 10"6 4.3 
Na + 239 57.3 6.9 x 10"6 4.2 
K* 261 62.7 1.6 x 10"5 3.8 
C a 2 + 264 30.6 2.3 x 10"3 3.6 
Table 4.3.1.1. Response of ISEs incorporating 2,6 didodecyl-p-cyclodextrin to R(+) and 
S(-) propranolol hydrochloride. 'Clinical' is a simulated background of clinical ions as 
chloride salts (1.45 xlO"1 mol dm"3 Na+, 4.3 x 10"3 mol dm"3 K + , 1.26 x 10"3 mol dm"3 
Ca 2 +). The initial potentials were recorded at 298 K relative to an external calomel 
reference electrode connected by a saturated KC1 salt bridge. 
The electrochemical results for S(+) and R(-) amphetamine hydrochloride also showed 
excellent response characteristics with 2,6 didodecyl-P-cyclodextrin as the ionophore. 
The electrodes showed a Nernstian response (~ 61 mV/decade) and reasonable limits of 
detection (LD>2.4 x 10"4 mol dm"3). The results with the ionophore were significantly 
better than those previously reported'171 when 'poly'octyl-a-cyclodextrin (contains 15.4 
octyl groups and 2.6 OH groups on average1231) was used as the ionophore. This may be 
due to several factors. One such factor is that is that it may be preferable for 
amphetamine to be included in the more rigidly defined dialkylated cyclodextrin (due to 
the complete retention of the 3 [OH]—[0]2 intramolecular hydrogen bonding) rather 
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than the more conformationally mobile 'poly'alkalyted host (table 4.3.1.2). Analysis of 
the results for both ionophores showed better results for the (+) enantiomer, inferring 
the existence of some additional interaction between the (+) enantiomer and 
cyclodextrin that was not present in the diastereoisomeric complex 
lonophore: 2,6 Didodecyl-P-cyclodextrin 
Initial E 
(mV) 
Gradient 
(mV/decade) 
limit of detection 
(mol dm"3) (mV) 
S(+) amphetamine 322 61.3 2.4 x 10"4 35 
R(-) amphetamine 283 62.4 3.5 x 10"5 
Ionophore: 'poly'octyl-P-cyclodextrin'171 
Initial E 
(mV) 
Gradient 
(mV/decade) 
limit of detection 
(mol dm"3) (mV) 
S(+) amphetamine 215.5 50.0 2.5 x 10"4 88.5 
R(-) amphetamine 127.0 37.0 unstable 
Table 4.3.1.2 Calibration results for S(+) and R(-) amphetamine hydrochloride 
at 298 K. 
Further experiments were carried out on (+) and (-) ephedrine hydrochloride using the 
dialkylated cyclodextrin 2,6 didodecyl-a-cyclodextrin, allowing comparison with the 
results using 'poly'octyl-a-cyclodextrin obtained previously t l 7 ]. The results with the 
new ionophore showed the same trend as noted previously for this analyte and with the 
other analytes studied in this section. A slightly sub-Nernstian response was obtained 
(55.0 and 54.0 mV/decade respectively for (+) and (-) enantiomers). The limits of 
detection were unstable with respect to time (table 4.3.1.3). From the initial potentials 
recorded (E° n i l ) , the (+) ephedrine appears to be the preferred guest, with a difference in 
the initial potentials of 9mV. Whilst this result was in the same sense as observed using 
the 'poly'octyl cyclodextrin, the AE value has been reduced. In addition, the difference 
in free energies calculated from the electrochemical and PGSE data (see section 4.3.3) 
are not consistent (though both data sets show the (+) enantiomer to be the more stable). 
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This could be related to the instability of the electrochemical response obtained for both 
enantiomers, leading to a AE value that was smaller than expected. 
lonophore: 2,6 DidodecyS-a-cyclodextrin8 
Initial E 
(mV) 
Gradient 
(mV/decade) 
Limit of detection 
(mol dm"3) (mV) 
(lS,2R)-(+) Ephedrine 343.0 55.0 Unstable 9 
(lR,2S)-(-) ephedrine 335.0 54.0 Unstable 
lonophore: 'poly'octyl-a-cyclodextrinb 
Initial E 
(mV) 
Gradient 
(mV/decade) 
Limit of detection 
(mol dm"3) (mV) 
(lS,2R)-(+) Ephedrine 233 60.0 2.5 x 10"7 26 
(lR,2S)-(-) ephedrine 207 50.0 5.0 x 10"7 
Table 4.3.1.3. Calibration results and enantioselectivity values for (+) and (-) ephedrine 
hydrochloride at 298 K. a membrane composition, ionophore, PVC, oNPOE, TKB. b 
membrane composition, ionophore, PVC, BBPA, TKB. 
4.3.2 Benzylamine Derivatives 
A series of chiral a-methyl-benzylamine derivatives was studied (figure 4.3.2.1) in an 
attempt to gain some insight into the nature of their binding interaction with lipophilic 
cyclodextrins. 
The response to R(+) and S(-) methyl benzylamine was studied using 2,6 didodecyl-ct-
cyclodextrin. As can be seen from the results shown (table 4.3.2.1.) the (+) enantiomer 
showed a Nernstian response (60.9 mV/decade), with a good limit of detection (8.9 x 
10"5 mol dm"3). The S(-) enantiomer showed a super-Nernstian response (64.6 
mV/decade) and a comparable limit of detection to that of the (+) enantiomer (8.9 x 10° 
mol dm"3). However, the difference in initial potentials apparently favours the (-) 
enantiomer. The response to these analytes was poorer than that observed for the 
clinical analytes discussed above (section 4.3.1). Also, the sensitivity of the 
cyclodextrins appears to favour inclusion of the (-) enantiomers, as opposed to the (+) 
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ones noted in the clinical analytes. It must be remembered that in these compounds the 
chiral centre is a to the aromatic group, in contrast to the amphetamine series of 
molecules, where it was p. 
NH 2 
R(+)-a-Methyl benzylamine 
" I I H 
NH, 
.•"MNH2 
H 
S(-)-a-Methyl benzylamine 
H 
0 ,N' 0 7 N ' 
R(+)-a-Memyl-4-mtroben2ylamine S(-)-a-Memyl-4-nitrobenzylamine 
^NH 2 
v 
NH, 
R(+)-1 -(1 -Naphthyl)ethylamine S(-)-1 -(1 -Naphthyl)ethylamine 
Figure 4.3.2.1. Chiral a-methyl-benzylamine and naphthylethylamine derivatives 
studied. 
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Initial E 
(mV) 
Gradient 
(mV/decade) 
Limit of Detection 
(mol dm"3) (mV) 
R(+) Methyl 
benzyiamine 
213 60.9 8.9 x 10"' 13 
S(-) Methyl 
Benzyiamine 
231 64.6 8.9 x 10"5 
Table 4.3.2.1 Calibration and enantioselectivity results for R(+) and S(-)-a-methyl 
benzyiamine at 298 K. Membrane composition, 2,6 didodecyl-a-cyclodextrin, PVC, 
oNPOE, T K B . 
Calibration and a limited set o f selectivity measurements were performed with R(+) and 
S(-) methyl-4-nitrobenzylamine (table 4.3.2.2). It was also decided to observe the effect 
o f changing the plasticizer f rom the phenolic oNPOE to the non-aromatic BBPA, since 
it is not unreasonable to hypothesise that the cyclodextrin cavity may include the 
oNPOE and hence affect the electrodes response characteristics. Indeed a-
cyclodextrins have been by shown Inoue [ 2 4 1 to include o-nitrophenol. The results (table 
4.3.2.2) revealed that changing the plasticizer f rom oNPOE to BBPA had only a minor 
effect upon the electrode response. A slight increase in the l imit o f detection for both 
analytes was found. One notable effect o f changing the plasticizer was to increase the 
AE./+ value f rom 6mV to approximately 30 mV. This change may be related to the 
removal o f the competing inclusion o f the plasticizer, The selectivity coefficients 
recorded for both enantiomers were good in a simulated clinical background 
( - l o g / C f , o v e r a l l s 2.6). 
The R(+) and S(-) enantiomers o f the l-(l-naphthyl)ethylamine (NEA) molecule were 
also examined. The calibrations were performed using 2,6 didodecyl-P-cyclodextrin as 
the ionophore. Results for both enantiomers (table 4.3.2.3) showed a super-Nernstian 
gradient (68 mV/decade and 66.3 mV/decade for R(+) and S(-) respectively) wi th 
moderate limits o f detection. Again, comparison o f the initial electrode potentials 
(E°nil) for both enantiomers showed that the (-) diastereoisomeric pair was bound more 
strongly (higher E°nU value). 
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S(-) Methyl-4-nitrobenzylamine 
Plasticizer I n i t i a l £ 
( m V ) 
Gradient 
(mV/decade) 
L D 
(mol dm" 3) 
BBPA Calibrat ion 252 61.8 1.5 x 10"6 
Clinical 241 59.9 3.8 x 10"4 2.6 
oNPOE Calibrat ion 240 60.3 1.2 x 10° 
R(+) Methyl-4-nitrobenzyIamine 
Plasticizer In i t i a l E 
( m V ) 
Gradient 
(mV/decade) 
L D 
(mol dm" 3) 
BBPA Calibrat ion 220 61.3 6.7 x 10"6 
Clinical 214 55.6 2.8 x 10"4 2.7 
oNPOE Calibrat ion 234 60.7 1.4 x 10"5 
Table 4.32.2 Calibration and selectivity data for R(+) and S(-) methyl-4-
nitrobenzylamine hydrochloride at 298 K. L D = Limi t o f Detection. 
In i t i a l E 
(mV) 
Gradient 
(mV/decade) 
L i m i t of detection 
(mol dm" 3) ( m V ) 
R(+) N E A 219 67.7 1.2 x 10"4 33 
S(-) N E A 252 66.3 1.1 x 10"5 
Table 4.3.2.3. Calibration and enantioselectivity results for R(+) and S(-) 1-(1-
naphthyl)ethylamine at 298 K. Membrane composition, 2,6 didodecyl-P-cyclodextrin, 
PVC, oNPOE, T K B . 
It may be that the pendant arm o f the S(-) enantiomer is able to rotate into such an 
orientation, that the interactions between it and the cavity r im are less unfavourable than 
for the R(+). When the chiral centre is further away from the aromatic group, as in the 
clinical analytes, the additional rotational freedom may allow the (+) enantiomers to 
gain a more compatible orientation with respect to the cyclodextrin. 
133 
4.3.3 Summary 
These electrode response studies serve to highlight the level o f enantiodifferentiation in 
working potentiometric electrodes. When the chiral centre is a to the aryl group, the 
S(-) enantiomer was bound more strongly, whereas with a chiral centre p to the aryl 
group, the (+) enantiomer is always the more strongly bound. To determine why this 
should be the case requires the use o f methods o f analysis that probe solution structure 
directly, such as NMR. 
4 . 4 S o l u t i o n N M R S t u d i e s o f H o s t G u e s t C o m p l e x e s 
N M R may be applied as a powerful tool in the study o f the inter- and intra- molecular 
interactions often present in cyclodextrin inclusion complexes. Various N M R 
techniques have been used to study the interactions between 2,6 didodecyl-a- and 2,6 
didodecyl-p-cyclodextrins wi th different arylammonium ions. A l l o f the N M R spectra 
were obtained in CDCI3 solutions, using the trifluoroacetate salts o f the chiral 
arylammonium ions. 
4.4.1 Chemical Shift Effects 
Monitoring the effects o f complexation by observing changes in the chemical shift o f 
selected resonances in host guest complexes is a widely used technique ! 2 5 ' 2 6 ' 2 7 ] . The 
inclusion o f a guest into the cavity o f cyclodextrin w i l l affect the local magnetic 
environment o f protons H 3 and H 5 on the inside o f the cavity, as wel l as those o f the 
guest molecule. This alteration in the proton environment leads to a change in the 
chemical shift o f the relevant signals. Such changes can provide information on the 
relative orientations and interactions between the host and guest molecules. 
Earlier studies 1 1 7 1 using FTIR and N M R reported the behaviour o f complexes o f 
ephedrine with 'poly'octyl-a-cyclodextrin. These studies identified the existence o f a 
strong intramolecular N H — O H interaction in both the free and bound states. The 
diastereotopic N H 2 hydrogens in the ephedrine trifluoroacetate were highly 
anisochronous in CDCI3 (AS = 1.03 ppm), which is consistent with the preferential 
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population o f a single conformation where the two hydrogens are in inequivalent 
magnetic environments. When the cyclodextrin was added, the (+) ephedrine (molar 
ratio 1:2.5 hostguest at 298 K ) showed an increase in the shift non-equivalence to 1.17 
ppm, with the higher frequency N H proton (9.42 ppm) shifted to higher frequency when 
bound (9.53 ppm), whereas the (-) ephedrine showed no change. This suggested that 
N - H interactions were important in determining the relative structures o f the two 
diastereoisomeric complexes, possibly involving intermolecular hydrogen-bonding of 
one o f the NHs to the cyclodextrin host. This interpretation agrees with the results o f 
N M R titration experiments performed by Petersheim' 2 8 ' which provided evidence 
showing that the ammonium group o f ephedrine (and pseudoephedrine) underwent 
hydrogen-bonding interactions with the secondary oxygens o f P-cyclodextrin. The 
studies showed the 2 ' and 3' hydroxy 1 resonances o f the (3-cyclodextrin undergo 
exchange broadening with increasing concentration o f drug, the degree o f exchange 
broadening was dependent upon the drug enantiomer present. 
In this work, the study has been extended to include several other P-arylammonium 
cations. In addition, a further study o f ephedrine, using 2,6 didodecyl-a-cyclodextrin as 
host has been undertaken in order to gain further understanding o f the inclusion process. 
The ' H N M R spectra o f propranolol (298 K, CDCI3) clearly shows the diastereotopic 
ammonium protons are anisochronous (AS = 1.07 ppm) in the free state (figure 4.4.1.1). 
This could be due to the presence o f intramolecular hydrogen bonding, which was 
supported by the observation o f a weak IR band at 3590 cm"1 in solution, whose 
position was independent o f concentration (figure 4.4.1.2). Upon complexation with 
2,6 didodecyl-P-cyclodextrin, the shift non-equivalence was 1.04 ppm for both 
enantiomers. However, for the complex with the R(+) enantiomer the shifts were 0.08 
and 0.09 ppm to higher frequency, whilst in the complex with S(-) propranolol, shifts o f 
0.01 and 0.05 to lower frequency were observed for N H a and NHb ( N H a denotes the 
proton resonating at higher frequency than NHb). This behaviour can be seen in figure 
4.4.1.3. 
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Figure 4.4.1.1. ' H N M R o f R(+) Propranolol, showing the anisochronous NH2 protons. 
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H H H + / 
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H H H H O H O H H + / \ r H N Np '"/// HOI"' O H H 
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\ 
Np ( N p = 1-naphthyl) 
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Figure 4.4.1.2. Intra- and Inter- molecular +N-H—O hydrogen bonding in Propranolol. 
136 
pTrrpnmrp111111111111111111 [ 1111111II1111111 i 111111111111111111111111 n 1111111111111II1111111111111111111111 n 111 n • 11 
9.8 9.6 9.4 9.2 9.0 8.8 8.6 8.4 8.2 8.0 ppm 
Figure 4.4.1.3. Changes in the *H N M R spectra o f protonated propranolol in the 
presence of 2,6 didodecyl-P-cyclodextrin. R(+) propranolol, lower; S(-) propranolol, 
upper; no cyclodextrin, centre. 
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This behaviour is consistent with the formation o f a slightly more well defined 
hydrogen bonded structure in the complex o f (+) with respect to that formed between (-) 
propranolol and the cyclodextrin. 
Unfortunately, due to the complexity o f the spectra, and the overlap of certain signals, 
changes in coupling constants could not be measured with any confidence, to allow 
information to be acquired on any rotational changes in the pendent arm upon 
complexation. Also, observation o f the chemical shifts o f the aryl region proved 
inconclusive (indeed as it would for this entire series o f compounds) since any shift 
changes that occurred were very small. For all these complexes changes in the chemical 
shifts o f H3 and H5 o f the cyclodextrin could be envisaged since they are situated on the 
interia o f the cyclodextrin cavity. Indeed, a study o f these protons has led to hypotheses 
about the direction and depth o f guest inclusion into the cavi ty [ 2 i ' 2 7 ! . Unfortunately in 
the case o f the complexes o f propranolol with 2,6 didodecyl-P-cyclodextrin (due to peak 
overlap), i t was impossible even at 500 M H z to discern which protons were due to H3 or 
H 5 . 
In the case o f amphetamine it was found (table 4.4.1.1) that the ammonium proton 
signal shifted to higher frequency for both enantiomers in the presence of both 2,6 
didodecyl-a- and P-cyclodextrin. The change was greater for the complexes wi th the 
alkylated P-cyclodextrin. The shift was probably due to formation o f hydrogen bonds 
between the ammonium group and the oxygens o f the secondary hydroxyls in the 
cyclodextrin. The changes were greater for the complex with P-cyclodextrin, showing 
that the environment o f those protons was being affected to a greater extent, probably 
due to a better size f i t between the analyte and host. The changes in the position o f the 
H3 signal (4.01 ppm) could this time be measured (though H5 (3.8 ppm) was still 
unavailable due to peak overlap). Although both the alkylated a- and P-cyclodextrin 
hosts induced a change in the chemical shifts o f the ammonium protons o f amphetamine 
(table 4.4.1.1), only the complex with 2,6 didodecyl-a-cyclodextrin showed any 
enantioselectivity. The slight difference may be due to different orientations o f the 
guest aromatic within the cavity. This variation in guest orientation may still be present 
in the p-cyclodextrin complex but the poorer host-guest f i t probably means it does not 
affect the signals to such an extent. 
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Guest Host A8NH(Free) ASNH(Bound) A N H a A N H b 
R(+) Propranolol 2,6 didodecyl-
P-cyclodextrin 
1.07 1.04 +0.08 +0.09 
S(-) Propranolol 1.07 1.04 -0.01 -0.05 
(+) Methamphetamine 2,6 didodecyl-
a-cyclodextrin 
0.16 0.15 +0.32 +0.38 
(-) Methamphetamine 0.16 0.19 +0.28 +0.33 
(+) Ephedrine 'poly'octyl-a-
cyclodextrin 
1.03 1.17 +0.11 -0.1 
(-) Ephedrine 1.03 1.03 0 0 
(+) Ephedrine 2,6 didodecyl-
a-cyclodextrin 
1.05 1.05 +0.42 +0.4 
(-) Ephedrine 1.05 0.97 +0.3 +0.4 
R(+) Amphetamine 2,6 didodecyl-
p-cyclodextrin 
- - +0.25 -
S(-) Amphetamine - - +0.25 -
R(+) Amphetamine 2,6 didodecyl-
a-cyclodextrin 
- - +0.15 -
S(-) Amphetamine - - +0.19 -
Table 4.4.1.1. Effect o f complexation upon the N M R shifts for ammonium protons o f 
the guests (Ephedrine wi th 'poly'octyl-a-cyclodextrin data f rom ref.17). 
Methamphetamine trifluoroacetate was also studied, and the diastereotopic ammonium 
protons were found to be anisochronous (A8 = 0.16), though not to the same extent as 
for propranolol and ephedrine, due to the lack o f internal hydrogen bonding (figure 
4.4.1.4). Upon complexation, the N H proton signals for both enantiomers were shifted 
to higher frequency (table 4.4.1.1) with the (+) enantiomer being affected marginally 
more. Again, it seems that both enantiomers are hydrogen bonding to the host 
cyclodextrin and the (+) enantiomer appears to shift the most. 
The work previously reported' 1 7 1 on the complexation o f ephedrine was continued by 
observing the effects o f complexation with 2,6 didodecyl-a-cyclodextrin. As discussed 
previously i n this section, the two diastereotopic ammonium protons o f ephedrine are 
anisochronous (A8 = 1.05 ppm) due to the intramolecular hydrogen bonding between 
one o f the ammonium protons and the hydroxyl group. Upon complexation with the 
cyclodextrin host, a shift to higher frequency for the ammonium signals o f both 
enantiomers was observed (table 4.4.1.1), showing that the environment around these 
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protons has been altered. In contrast to the results for the complexation with 
'poly'octyl-a-cyclodextrin, no noticeable increase in the anisochronaity o f the two 
protons in the (+) enantiomer was noted. However, there is a decrease for the (-) 
enantiomer The complexation o f the ephedrine enantiomers caused a shift in the 
signals due to the H 3 proton o f the cyclodextrin host (A5H3(+> = 0 . 0 2 , A5H3(.) = 0 . 0 3 ) 
which may be related to the inclusion o f the aromatic ring into the cyclodextrin cavity. 
These results are not the same as those observed for the 'poly'octyl system. This is not 
surprising as the didodecyl-a-cyclodextrin cyclodextrin probably has a more rigidly 
defined cavity geometry, because o f the greater degree o f 3 ( O H ) — ( 0 ) 2 , hydrogen-
bonding. 
O? CO D 
R(-) Metlramplietamine 
j J J L 
p p m 
Figure 4 . 4 . 1 . 4 . ' H N M R spectra of Methamphetamine trifluoroacetate ( 3 .3 x 10" 2 mol 
dm" , 298 K , CDCI3). Highlighted are the NHg and N H b ammonium protons. 
For amphetamine and methamphetamine it is not surprising that the differences in 
chemical shift changes between enantiomers are similar. Both analytes have mobile 
side chains, because there is no intramolecular hydrogen bonding. In both ephedrine 
and propranolol this free rotation is restricted, making it harder for the pendant chain to 
orientate itself into a suitable conformation to allow maximum stabilising interactions 
between the guest and host. 
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4.4.2 Relaxation Rate measurements 
Measurements fol lowing the changes in proton relaxation rates (Ri = 1/Ti) for the host 
and guest molecules were used in an effort to define further the structural differences in 
the diastereoisomeric complexes. This method is useful because it is known that the 
measured relaxation rates are sensitive to a wide variety o f factors including solvent, 
temperature, relative conformational population, exchange dynamics and intermolecular 
distances. This study was performed to compare Ri data obtained for the 
diastereoisomeric complexes under controlled conditions, and to elucidate reasons for 
any differences, paying particular attention to the behaviour o f the N H protons. 
1 4 1 
-»-» 
a 
o 
s 
s 
© 
P6 
o 
3 O 
oa 
co 
o 
od 
SO 
o 
CN 
© 
CN 
co 
O N 
"3-00 
so 
© 
co 
CN 
o 
+ 
oo 
so 
in 
SO 
oo 
O 
so 
ON 
SO 
00 
CM 
co 
co 
in 
O0 
00 
CN 
© 
so 
oo' 
oo 
00 
o 
o 
CN 
CN 
+ 
in 
SO 
co 
CN 
+ 
in 
so 
co 
m 
o 
+ 
co 
co 
oo 
O 
O N 
SO CN 
SO C O 
in 
in o 
CN 
© 
+ 
o oo 
oo 
in 
in 
SO 
00 
in 
o 
CN 
m 
co' 
© 
CN 
OS 
r-' 
Os 
CN 
O SO 
in 
en 
Os 
m 
^' 
o 
+ 
in r--
o 
SO 
o 
co 
so 
so 
C O 
in 
Os 
C O 
in 
SO 
SO 
ON 
CN 
C N 
SO 
in 
SO 
© 
in 
CN 
o 
©' 
m 
o 
+ 
SO 
so 
in 
C O 
so 
o 
CN 
SO 
SO 
SO 
© 
+ 
00 
C O 
OS 
Os 
SO 
o 
CN 
£ 3 
V o 
o * 
EC EC 
o 
w 
Q 
U 
ca 
u 
so^ 
CN 
Q 
U ax 
I N 
6 
CN 
Q 
U 
a 
oo 
u 
Q 
u 
a 
s© 
rsf 
Q 
U 
a 
U 
so^ 
CN 
Q 
U 
a 
u 
SO^  
CN 
s 
c 
s 
s 
o c 
o 
t-l 
Oh 
a. 
W W 
1> 
C 
S 
.3 
2 
CD 
C 
J3 
C l 
As can be seen f rom table 4.4.2.1 the relaxation rates for the N H 2 + protons o f 
propranolol are enantiomer dependent. The rates for both N H protons in the more 
weakly bound complex with S(-) propranolol showed a marked decrease upon 
complexation. With the R(+) enantiomer an increase by 1.0 s"1 for N H a was found 
while NHb remained unchanged. 
Generally, Ri values decrease through inhibition o f relaxation mechanisms that decrease 
the local reorientation correlation time through increased molecular motion. Relaxation 
rates may be increased following complexation with a large host molecule, due to a 
decrease in molecular motion, ©, as a result o f the association with the large molecule. 
The establishment o f a new relaxation pathway such as that provided by hydrogen 
bonding between a guest and host also needs to be taken into account. Molecular 
modelling studies have been performed between propranolol and native P-cyclodextrin 
by Armstrong' 2 9 1 . It was suggested that the inclusion complex was formed by the 
inclusion o f the naphthalene ring into the cyclodextrin cavity wi th the pendant arm 
available for hydrogen bonding to the secondary hydroxyls o f the host. The distances 
calculated between the N H 2 + group o f both enantiomers and cyclodextrin hydroxyls are 
shown in table 4.4.2.2. The shortest distances are between N H 2 + - 3[OH], for the R(+) 
enantiomer, and N H 2 + - 2 [OH] for the S(-) enantiomer. 
N H 2 + - 2 [ O H ] / A N H 2 + - 3 [ O H ] / A 
R(+) Propranolol 3.3 2.8 
S(-) Propranolol 3.8 4.5 
Table 4.4.2.2. Calculated distances f rom the N H 2 group o f protonated propranolol to the 
secondary hydroxy 1 groups o f the P-cyclodextrin [ 2 9 ]. 
This pattern is consistent wi th the data obtained from the Ri measurements. A J I 
increase in relaxation rate for NHa was found. This proton (NHa) o f the R(+) 
enantiomer is probably hydrogen bonding to the host 2,6 didodecyl-P-cyclodextrin 
(3 [OH] o f the cyclodextrin), NHb meanwhile may now be hydrogen bonding (as the 
proton donor) to 2 [ 0 ] . This possible hydrogen bonding coupled, wi th the expected 
increase in relaxation rate due to inclusion, may be enough to compensate for the 
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decrease in relaxation rate due to inhibition o f relaxation caused by hydrogen-bonding 
to water dissolved in the solvent. The S(-) enantiomer shows a decrease in rate for both 
NH2 + protons, although the decrease is less for NHt,. This is consistent wi th neither o f 
the NH2 + protons being able to hydrogen bond to the host (distances are too great) and 
their inability to relax via water in the solvent. The absence of these relaxation 
mechanisms leads to a decrease in the relaxation rate o f the NH2 + protons. 
For all the other analyte-cyclodextrin complexes studied (table 4.4.2.1) it was found that 
the relaxation rate was decreased upon complexation. This is indicative o f the 
suppression o f at least one dipolar relaxation pathway that effectively increases the local 
motional mobility, hence decreasing the local reorientation correlation time. This 
process may be related to changes in the hydrogen-bonding state o f the N H 3 + and NH2 + 
protons, which in the free state are probably hydrogen-bonded to residual water (from 
the salt or solvent). Complex formation w i l l cause a decrease in the extent o f this 
relaxation mechanism, as hydrogen bonding to the host cyclodextrin becomes 
competitive. Counteracting this tendency is the increase in R\ values expected when a 
small guest associates with a large molecule. Given the opposing nature o f these 
mechanisms on R] , the overall observed effect w i l l be a function o f the difference in 
equilibrium constants for formation o f the diastereoisomeric complexes and the change 
in the degree o f N H — O hydrogen bonding. In these analyte-cyclodextrin complexes 
the evident decrease in relaxation rates could well be due to a decrease in hydrogen 
bonding. 
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4.4.3 Pulsed-Gradient Spin-Echo Measurements of Complex 
Stabilities 
Pulsed-gradient spin echo N M R measurements o f diffusion coefficients (section 
4.2.1.4) were kindly performed by Professor Yoram Cohen. The association constants 
for 1:1 complex formation between the trifluoroacetate salts o f the enantiomers o f 
propranolol, ephedrine and amphetamine with 2,6 didodecyl-a- and (3-cyclodextrin 
were calculated. 
Table 4.4.3.1 shows the results obtained for all the systems studied. The complex 
between R(+) propranolol and 2,6 didodecyl-P-cyclodextrin is the most strongly bound. 
The association constant (Ka = 222 ± 5 8 dm 3 mol" 1) is consistent with reported affinities 
o f P-cyclodextrin for 1 -substituted naphthyl derivatives' 3 0 1. The S(-) enantiomer was 
more weakly bound ( K a = 66 ± 17 dm 3 mol" 1), corresponding to a free energy difference 
o f 2.8 kJ mol" 1. Both the sense and the magnitude o f this enantioselectivity are 
consistent with the electrochemical studies and values estimated f rom chiral HPLC 
methods 1 2 3 1. 
In the two other cases studied, a more modest selectivity was observed, but the (+) 
enantiomer was always the more strongly bound. As a control, a cyclodextrin host wi th 
the 3[OH] alkylated was used in conjunction with ephedrine: no enantioselectivity was 
observed ( K a = 113 dm 3 mol" 1 for (-) ephedrine, K a = 113 d m 3 mol" 1 for (+) ephedrine). 
Alkylat ion o f the 3 [OH] position removes the intramolecular hydrogen bonding 
network from the cyclodextrin. The interaction between 3 [ O H ] — [ 0 ] 2 provides 
conformational rigidity to the host molecule. Prior electrochemical response studies 
had also showed that complete alkylation o f these lipophilic cyclodextrins removes the 
enantiodiscrimination for ephedrine and its stereoisomers'171. 
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System CD 
( x l O 5 cmV 1) 
Analyte 
( x l O 5 c m 2 s ' ) 
Ka 
(drn'mol"1) 
2,6 Ci 2aCD 0.32±0.01 - - -
S(-) Ephedrine - 0.66±0.02 - -
R(+) Ephedrine - 0.66±0.02 - -
2,6 Ci 2aCD+ R(+) 
Ephedrine 
0.28+0.01 0.51+0.01 142121 1.2510.25 
2,6 C 1 2aCD+ S(-) 
Ephedrine 
0.28±0.01 0.54+0.01 114115 
2,6Ci23CiaCD 0.39±0.01 - - -
2,6C123C,aCD+S(-) 
Ephedrine 
0.31±0.01 0.52±0.01 113+19 1.0010.24 
2,6C 1 23daCD+R(+) 
Ephedrine 
0.31±0.01 0.52+0.01 113119 
2,6C12PCD 0.33±0.01 - - -
S(+) Amphetamine - 0.69+0.01 - -
R(-) Amphetamine - 0.69±0.02 - -
2,6Ci2pCD+S(+) 
Amphetamine 
0.31±0.01 0.48±0.01 163128 1.6010.37 
2,6C12pCD+R(-) 
Amphetamine 
0.31±0.01 0.5110.01 102+16 
S(-) Propranolol - 0.59±0.02 - -
R(+) Propranolol - 0.59+0.02 - -
2,6C12PCD+S(-) 
Propranolol 
0.30+0.01 0.53+0.02 67117 3.3111.2 
2,6C,2pCD+R(+) 
Propranolol 
0.24+0.01 0.4510.02 222158 
Table 4.4.3.1 Diffus ion coefficients (D in cmV1) o f the chiral ammonium salts and o f 
the cyclodextrins studied in the free and in 1:1 solutions along with association 
constants (Ka in d m 3 m o r ' ) derived f rom the data. Measurements were made at 283 K, 
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4.5 Conclusions 
The data f rom both the N M R and electrochemical response studies show, for this range 
o f analytes, that the (+) enantiomer is more strongly bound. The variation in the 
strength of complexation between enantiomers is probably due to an increase in the 
degree o f hydrogen bonding observed upon complexation o f the (+) enantiomer 
(involving N H a ) . The complexation o f propranolol shows this best, and the R(+) 
enantiomer is more strongly bound by 2.6 - 2.9 kJ mol" 1 (evidence f rom PGSE and 
electrochemistry). There is evidence that stabilising N H - O interactions are present 
between propranolol and 2,6 didodecyl-|3-cyclodextrin that are absent in the weaker 
isomeric complex. Earlier molecular modelling calculations are consistent wi th this 
result, showing that N H 2 + - OH distances in the complex with (+) propranolol are short 
enough to allow hydrogen bonding, while the corresponding distances in (-) propranolol 
are longer. 
The case o f the benzylamine derivatives is different. Although too much emphasis 
should not be placed on the electrochemical data without corroborating evidence, it can 
be deduced that in all the cases studied, the (-) was more the strongly bound. This 
change in preference may be due to a number o f reasons, not least o f which would be 
the different position o f the chiral centre: here being a to the aromatic ring rather than 
further along a pendent chain. However, more experiments need to be done relate this 
change to the precise solution structure o f the complex. 
It must also be noted here that enantioselectivity is only a small part o f the overall 
association constants for pairs o f diastereoisomers. The forces involved are typically 
1-2 orders o f magnitude weaker than those responsible for general complexation, the 
main energy gain coming from the substitution o f the energetically unfavourable polar-
apolar interactions between the included water and the cyclodextrin cavity wi th the 
more favourable apolar-apolar interactions between the guest and cavity. This can be 
seen by referring back to table 4 .4 .3 .1 . In all of the cases studied the 
enantiodiscrimination free energy difference is consistently an order o f magnitude 
smaller than that required to form the complexes. Even so, the relatively small amount 
o f energy involved is enough to dictate the selectivity o f the host cyclodextrin for the 
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potential chiral guest molecule. The enantiodiscrimination observed here is clearly the 
result of the overall effect of some nonbonding interactions, and in particular is due to 
the difference in hydrogen-bonding between the guest molecules and the host. 
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Chapter Five 
General Experimental Procedures 
5.1 Potentiometric Methods 
5.1.1 Ion-selective Membrane Composition 
The electroactive membranes were prepared containing the appropriate ionophore 
(1.2%), o-nitrophenyloctyl ether (oNPOE), bis(butylpentyl)adipate (BBPA) or bis(2-
ethylhexyl)sebacate (DOS) (65.6 % ) , PVC or Tecoflex SG80 (32.8 %) and Sodium 
tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (TKB) or potassium tetrakis(4-
chlorophenyl)borate (KTC1PB) (0.4 %) in 6 cm 3 THF (see figure 5.1.1.1 for structures). 
The membranes were cast according to the procedure described by Moody1'1. 
The PVC, oNPOE, DOS and KTC1PB were obtained from Fluka. Tecoflex SG80 was 
obtained from Thermedics Inc. (USA), TKB was synthesised in this laboratory. 
O o 
CI B K 
NO, 
KTC1PB O O 
oNPOE BBPA 
\ O O 
X BNa 3H->0 V / / 
o o 
DOS T K B 
O O 
O -(CH^HjCHjCH^O O—CHCH2CH2CH2 0 N N 
H H H 
Tecoflex SG 80 
Figure 5.1.1.1. Membrane Constituents. 
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5.1.2 Constant Volume Dilution Method. 
This method was first introduced by Horvai et al.[ J in 1976 and has since been widely 
used as a calibration method and also in the determination of electrode parameters. 
With this method the concentration of an analyte ion can be varied with time or diluent 
volume. I f the electrode response follows the Nernst equation then the measured 
potential difference E, is proportional to log c as long as the activity coefficient remains 
constant. The electrode will then produce a linear response of E versus t. 
The method requires the continuous dilution of a fixed volume of solution containing 
the primary ion, either by water, for a calibration graph or by a background electrolyte, 
for selectivity measurements. The system must also have efficient stirring to maintain a 
homogenous solution during the experiment'3]. 
Derivation of the log c <-> t relationship; 
5v 
o 
After a given time interval a small volume of solution 5v is removed from the cell and 
replaced with diluent which does not contain the primary ion, 
v 0 - v D = £ v (1) 
This gives the new lower concentration (c') of the primary ion in the cell by the 
equation, 
c , = cv = c(v 0 - < ?v) ( 2 ) 
v 0 v 0 
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Re-arranging and substituting 8c = c' - c 
S c _ S v 
c v„ 
(3) 
I f the dilution is continuous 8v -» dv, 
^ = ^ (4) 
c v„ 
I f the flow rate is w ( m V ) , then dv = wdt, 
substituting for dv and integrating, 
wt 
then In c = In c 0 (6) 
v r '0 
where Co: initial concentration of primary ion 
c : concentration of primary ion at time t 
As the results are initially in the form of potential difference vs. time and the graphs 
presented are in the form potential difference vs. -log c, the following conversion is 
used for time into -log c, 
( - * t / A 
- log c = - log c0 + log e ' v° (7) 
V J 
This technique was used as the standard method for obtaining calibration and selectivity 
measurements. The constant volume dilution system was set-up as shown in figure 
5.1.2.1. The solution was drawn through the constant volume cell and past the frit of 
the T-junction reference electrode (figure. 5.1.2.2) vessel to waste and the electrode 
response was monitored with respect to time. 
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The flow rate was measured by timing the filling of a 10 ml volumetric flask by the 
waste solution. The volume of the constant volume cell was calculated by measuring 
the time taken to f i l l the cell from the input to the output. This time was then converted 
to a volume using the flow rate calculated earlier. The system was thermostatted at 
298 K. 
The constant volume cell and T-junction reference cell were both made in-house. A 
7mm disc of the electroactive membrane was cut and mounted in a Philips IS(561) 
electrode body (Philips Analytical, Eindhoven, Netherlands). The inner filling solution 
was 1 x 10"3 mol dm"3 ammonium chloride (Merck, UK), and the reference electrode 
was a single junction calomel electrode (ATI Russell, Fife, Scotland) with saturated 
potassium chloride as the bridging solution. The peristaltic pump was a Minipuls 3 
(Gilson). 
The Philips body electrode and reference electrode were connected to a high impedance 
buffer amplifier, which was attached to a digital multimeter (Keithley) and a chart 
recorder. 
The parameters required for equation 7 were calculated to be; 
Flow rate (w) = 0.8 ml min"1 
Cell volume (v 0) = 2.34 ml 
A stable reading was obtained with the initial solution flowing before the dilution was 
initiated. 
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Figure 5.1.2.1. Constant volume dilution schematic. 
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Figure 5.1.2.2. Schematic of Reference Cell 
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5.1.3 Fixed Interferent Method 
To calculate the selectivity coefficient the fixed interferent method (FIM) was used[4]. 
The method involves the variation of either the interferent or the primary ion 
concentration while the other is kept constant. 
a) Fixed primary ion concentration. 
The concentration of the primary ion is kept constant and the interferent ion 
concentration is varied. 
b) Fixed interferent ion concentration. 
The concentration of the interferent ion is kept constant while the concentration of the 
primary ion is varied. This method is preferred as it usually provides a more realistic 
simulation of the situation in samples. Indeed, this was the method used in the 
interference studies. The selectivity coefficient for the concentration of interferent can 
be obtained from a plot of E vs. -log c. 
E / m V x Response to i 
sponse to j 
Figure 5.1.3.1. Mixed Solution Plot. 
I f the plot of E vs. -log c levels out at low concentrations, the point where the two 
extrapolated linear regions intersect is the point c', where the electrode is responding 
equally to both the primary and interferent ions, see figure 5.1.3.1. 
At high concentrations the potential difference only depends on the primary ion, 
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E ^ E o + k logCj (1) 
At low concentrations the potential will depend only on the interferent ion, 
E, = E 0 +k log (2) 
At the point c' the electrode is responding equally to both ions i.e. this concentration of 
primary ion as the interferent ion, therefore, 
therefore giving, 
C - k y a / ' (3) 
(4) 
I f however the plot of E vs. -log c does not level out at lower concentrations of the 
primary ion then the following can method can be used, as in figure 5.1.3.2, 
Emf/mV Response to i 
AE 
logc 
Figure 5.1.3.2. 
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For pure ion i calibration, 
E ^ E o + klogc, (5) 
For the mixed solution, 
E' = E 0 + klog 
f v" \ 
c + k c-
» « J (6) 
When c; = c' = kijCj the difference in potential, AE, between the pure primary ion 
solution and the mixed ion solution, each with primary ion concentration c' is, 
AE = E' - Ej = k log 2 (7) 
. 2.303RT „ 
AE = — - l o g 2 (8) 
z,F 
AE s — mV (9) 
Therefore c' can be found by extrapolating the linear section of the plot from high 
concentration to the point at which the deviation between the two lines is 18/z, mV. 
5.1.4 Flow Injection Analysis 
The Flow Injection Analyser was configured as shown in figure 5.1.4.1. The carrier 
was drawn through the injector, dispersion coil and detector, to waste, by the peristaltic 
pump (Ismatec SA, Switzerland). Samples were introduced into the flow system by 
means of a six-port manual injector with a sample loop volume of 250 j ^ l . 
The dispersion coil consisted of 1 m Teflon tubing ( lm, i.d. 0.5 mm, o.d. 1 mm). The 
detector cell configuration was a macro wall-jet system (figure 5.1.4.2). This consisted 
of a potentiometric wall-jet cell arrangement with small effective volume with a macro 
ion-selective electrode as the detector. A Philips IS-560 electrode body (Philips 
Analytical, Eindhoven, Netherlands) and a single junction calomel electrode (ATI 
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Russell, Fife, Scotland) with bottom ceramic-frit were fitted into the detector cell body. 
The reference electrolyte (1 x 10"1 mol dm"3 KC1) flowed continuously around the 
reference electrode frit, forming a thin f i lm of flowing solution around the ion-selective 
electrode as it entered the reservoir. The carrier stream impinged directly onto the ion-
selective membrane surface through a capillary. The capillary to electrode membrane 
distance was approximately 2 mm. 
The ion-selective electrode and reference electrode were connected to an amplifier unit 
(Molspin Ltd, Newcastle, UK) which supplied a voltage gain of three. The amplifier 
was then connected to a digital multimeter (Metex M4650CR), and the EMF response 
was displayed on a PC. 
Al l measurements were performed at room temperature. For each analyte sample, 
multiple injections of that sample were made to check the reproducibility of the 
potential difference measured. The flow rate of the system was measured by timing the 
filling of a 10 ml volumetric flask, flow rate 4 ml min"1. In all the measurements, a 
steady potential for the carrier solution was obtained before injecting the first sample. 
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Figure 5 .1.4.1. Schematic of Flow Injection Analyser. 
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Figure. 5.1.4.2. Flow Injection Analyser Detector Cell [ 5 l 1, ISE; 2, ion-selective 
membrane; 3, reference electrode; 4, bore for continuously streaming reference 
electrolyte; 5, jet; 6, outlet. 
5.1.5 Protein Interference Dip Tests 
The electroactive membranes were mounted in Philips IS-560 electrode bodies and the 
reference electrode was a double junction silver-silver chloride (RE 15, Unicam) with 
10% Potassium nitrate as bridge solution. 
The protein solutions studied were, 
1) 40 g/1 Bovine Serum Albumin 
2) 0.55 g/1 oti-acid glycoprotein 
3) Pooled Human Serum 
For each of the protein interferents studied two solutions were prepared, 
1. containing 1 x 10" mol dm" analyte in 'clinical background' cations, 
2. 1x10" mol dm" analyte with the protein and 'clinical background' cations. 
The ISE and reference electrode were placed in the stirrer protein-free solution and the 
potential difference recorded after 20 min. The electrodes were then washed before 
being placed in the protein containing solution, the potential difference was again 
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recorded after 20 min. After re-washing the electrodes in de-ionised water, they were 
returned to the aqueous solution. This process was repeated 10 times for each pair of 
solutions. 
All solutions were prepared using de-ionised water. 
All measurements were made at 298 K. 
Both the electrodes were connected to a buffer amplifier and the EMF response was 
recorded on a digital multimeter (Keithley). 
5.2 Amperometric Experimental 
5.2.1 Square Wave Voltammetry 
This technique was used for all the amperometric experiments performed due to its 
quantitative nature. The equipment was set-up in three configurations; ^ 
1) A glassy carbon working electrode (BAS Technical, Stockport, UK) with a silver-
silver chloride reference electrode and a platinum wire counter. The working 
electrodes were polished with 0.05 p.m alumina slurry (Buchler, Lake Buff, USA), 
washed thoroughly and dried before use. The glassy carbon electrode was used 
either uncoated or coated with an alkylated cyclodextrin solution depending on the 
actual experiment. 
2) A screen printed PVC substrate which consisted of a carbon working electrode 
(surface area, 0.12 cm2) and a silver-silver chloride reference electrode (Cambridge 
Life Sciences, Ely, UK) with a separate platinum wire counter electrode. 
The surface of the working electrode could be modified as required by depositing 
l\x\ aliquots of membrane material onto its surface. The modification used 
depended upon the analyte of interest. 
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5.2.2 Controlled Potential Coulometry 
A MF-1056 electrolysis cell (BAS Technical, Stockport, UK) was used for the 
controlled potential coulometry This consisted of a porous carbon working electrode, a 
silver chloride reference and a platinum wire counter electrode 
In these experimental set-ups the voltammograms were recorded using an EG & G 
PARC (Princeton, NJ, USA) Model 263 or M273 with model M270/250 software. Data 
analysis was performed using EG & G Model 271 Cool Kinetic Analysis Software. 
5.3 NMR Experimental 
5.3.1 Longitudinal Relaxation (Ri) Experimental 
The experiments were performed on a Bruker AMX 500 spectrometer using the 
standard inversion recovery technique16'. 
Paramagnetic oxygen was excluded from the samples by a repetitive 'freeze-pump-
thaw' process carried out under an argon atmosphere. For each complex investigated, 
four solutions were prepared with the guest being present as the trifluoroacetate salt; 
1) Free guest, 3.3 x 10"2 mol dm"3 
2) Free host cyclodextrin, 1.32 x 10"2 mol dm"3 
3) R enantiomer guest (3.3x 10"2 mol dm"3) + 
host cyclodextrin (1.32 x 10"3 mol dm"3) 
4) S enantiomer guest (3.3x 10"2 mol dm"3) + 
host cyclodextrin (1.32 x 10"3 mol dm"3) 
Each solution was prepared in 0.7 ml d-chloroform. Al l the solutions were 
deoxygenated by a repetitive 'freeze-evacuate-thaw' process carried out under an argon 
atmosphere. The guest analyte was in the form of a trifluoroacetate salt, the preparation 
of which is described in section 5.3.2. 
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5.3.2 Preparing the trifluoroacetate salt 
A solution of the required analyte hydrochloride in de-ionized water was basified to pH 
9/10 with 4 mol dm"3 sodium hydroxide The resulting solution was extracted into 
dichloromethane. The combined organic residues were dried over anhydrous potassium 
carbonate and filtered. An excess of trifluoroacetic acid was added and the resulting 
solution was dried under reduced pressure to give a viscous oil. 
5.3.3 Pulse Gradient Spin Echo (PGSE) 
The PGSE diffusion experiments were performed at 283 K on a Bruker ARX500 
spectrometer equipped with a BGU pulsed gradient unit on a B-VT-2000 temperature 
control unit. Data was collected using a commercial 5 mm inverse probe equipped with 
shelf-shielded g-gradients on 5 x 10"J mol dm"3 samples in d-chloroform. The guest 
molecule was in the form of a trifluoroacetate salt, the preparation of which is described 
in section 5.3.2. 
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Appendix 
Research Colloquia, Conferences and Publications 
The author attended the following lecture courses: 
NMR Spectroscopy, by Dr. A. M. Kenwright, Dr. P. G. Steel and Prof. D. 
Parker 
Diffraction Techniques, by Prof. J. A. K. Howard 
Physical Chemistry of Polymers, by Prof. R. W. Richards 
The author attended the following colloquia between October 1994 and September 
1997. 
1994 
October 4 Prof. N.L. Owen, Brighton Young University, Utah, USA 
Determining Molecular Structure - the INADEQUATE NMR way 
November 2 Dr. P. G. Edwards, University of Wales, Cardiff 
The Manipulation of Electronic and Structural Diversity in Metal 
Complexes - New Ligands 
December 7 Prof. D. Briggs, ICI and University of Durham 
Surface Mass Spectrometry 
December 13 Prof. H. A. O. Hil l 
Making use of one electron after another 
1995 
January 18 Dr. G. Rumbles, Imperial College, London 
Real and Imaginary Third Order Non-linear Optical Materials 
February 1 Dr. T. Cosgrove, Bristol University 
Polymers do it at Interfaces 
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February 17 Prof. B. Birch, Luton University 
Disposable Sensors 
May 4 Prof. A. J. Kresge, University of Toronto 
The Ingold Lecture Reactive Intermediates: Carboxylic-acid Enols and 
Other Unstable Species 
November 9 Prof. R. J. P. Williams 
Metals in Health and Disease 
November 17 Prof. D. Bergbreiter, Texas A & M , USA 
Design of Smart Catalysts, Substrates and Surfaces from Simple 
Polymers 
November 23 Dr. P. Levy 
Drug Abuse in Sports 
1996 
January 10 Dr. B. Henderson, Waikato University, NZ 
Electrospray Mass Spectrometry - a new sporting technique 
January 17 Prof. J. W. Emsley, Southampton University 
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